1
|
García-Arnáez I, Romero-Gavilán F, Cerqueira A, Elortza F, Azkargorta M, Muñoz F, Mata M, de Llano JM, Suay J, Gurruchaga M, Goñi I. Correlation between biological responses in vitro and in vivo to Ca-doped sol-gel coatings assessed using proteomic analysis. Colloids Surf B Biointerfaces 2022; 220:112962. [DOI: 10.1016/j.colsurfb.2022.112962] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Revised: 10/10/2022] [Accepted: 10/20/2022] [Indexed: 11/13/2022]
|
2
|
Lemos M, Rato J, Mata M, Sequeira M, Cordeiro Mendes S, Carmo Mendes I, Anjos R. Advanced echocardiographic function analysis in adolescents and young adults with corrected and residual coartation of the aorta. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
This study aimed to assess systolic and diastolic heart function changes in patients with history of aortic coarctation using advanced echocardiographic imaging. Additionally, we sought to analyse which severity factors influenced these changes.
Methods
We performed a complete echocardiographic evaluation, with advanced functional analysis, including myocardial work analysis, to a random sample of 53 patients (age 12 to 40 years). These had a previous history of coarctation of the aorta (CoAo), which was either corrected (aortic transisthmic Doppler gradient (Dgrad) ≤20mmHg) or presented a significant residual gradient (Dgrad >20mmHg). A control group of healthy individuals, matched for age, sex and BMI, was subjected to the same evaluation. Selected dependent variables were: E/A, E’, E/E’, atrial strain parameters, biplane ejection fraction, ventricular global longitudinal strain, and global myocardial work (GMW). One-way ANOVA with appropriate post-hoc tests was done to compare the distribution of dependent variables among controls (n = 31), patients with corrected coartation (cCOAO) (n = 36), and patients with residual coartation (rCOAO) (n = 17). Multivariable linear regression was used to evaluate the association, in the 53 patients, between the dependent variables and parameters of CoAo severity: systolic blood pressure (SBP), left ventricular indexed mass (LVmass), Dgrad, and the ratio of the narrowest diameter of the aortic arch to the aorta at the diaphragm level (Aoratio). Statistical significance was established as p < 0.05.
Results
Patients with either cCOAO or rCOAO had lower E’ (p < 0.001), higher E/E’ (p < 0.001), lower atrial reservoir (p < 0.001) and conduit (p < 0.001) strain, when compared with controls (table 1). Patients with rCOAO had higher GMW when compared with either cCOAO or controls (p = 0.002). Multivariable regression analysis showed that both lower atrial reservoir and conduit strain were associated with a narrower aortic arch (lower Aoratio (p = 0.002 and p = 0.011, respectively); higher E/E’ with higher LVmass (p = 0.030); higher GMW with higher LVmass (p = 0.027) and Dgrad (p = 0.035). Patients subsequently submitted to an intervention for coartation treatment (n = 8) had lower atrial conduit (p = 0.007) and higher GMW (p = 0.015) when compared to all other patients (n = 45). Conclusion: Myocardial work emerged as a particularly useful tool as it was both significantly different between CoAo groups, and significantly higher in more severe patients, driven by the LV mass and residual gradient. This analysis may have a role in these patients’ clinical decision-making. Abstract Table 1
Collapse
Affiliation(s)
- M Lemos
- Hospital Santa Cruz, Lisbon, Portugal
| | - J Rato
- Hospital Santa Cruz, Lisbon, Portugal
| | - M Mata
- Hospital Santa Cruz, Lisbon, Portugal
| | | | | | | | - R Anjos
- Hospital Santa Cruz, Lisbon, Portugal
| |
Collapse
|
3
|
García-Ramos R, Santos-García D, Alonso-Cánovas A, Álvarez-Sauco M, Ares B, Ávila A, Caballol N, Carrillo F, Escamilla Sevilla F, E. Freire, Gómez Esteban J, Legarda I, López Manzanares L, López Valdés E, Martínez-Torres I, Mata M, Pareés I, Pascual-Sedano B, Mir P, Martínez Castrillo J. Management of Parkinson’s disease and other movement disorders in women of childbearing age: Part 1. Neurología (English Edition) 2021. [DOI: 10.1016/j.nrleng.2020.05.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
4
|
García-Ramos R, Santos-García D, Alonso-Cánovas A, Álvarez-Sauco M, Ares B, Ávila A, Caballol N, Carrillo F, Escamilla Sevilla F, Freire E, Gómez Esteban J, Legarda I, López Manzanares L, López Valdés E, Martínez-Torres I, Mata M, Pareés I, Pascual-Sedano B, Mir P, Martínez Castrillo J. Manejo de la enfermedad de Parkinson y otros trastornos del movimiento en mujeres en edad fértil: Parte 1. Neurologia 2021; 36:149-158. [DOI: 10.1016/j.nrl.2020.05.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2020] [Accepted: 05/05/2020] [Indexed: 02/07/2023] Open
|
5
|
Rodríguez-Sanz A, Peña-Llamas E, Alonso-Cánovas A, Alonso-Frech FA, Borrue-Fernández C, Catalán MJ, Fanjul-Arbós S, García-Cobos E, García-Ramos R, García Ruiz-Espiga P, Herreros-Rodríguez J, Kurtis-Urra M, López-Lozano JJ, López-Manzanares L, Martínez-Castrillo JC, Martínez-Fernández R, Mata M, Pérez-Sánchez JR, Posada IJ, Rojo A, Romero-Muñoz JP, Ruiz-Huete C, Sánchez-Alonso MP, Vivancos-Matellano F, En Representación Del Grupo de Trastornos Del Movimiento de la Asociación Madrileña de Neurología ERDGDTDMDLAMDN. [Clinical experience in the treatment of motor fluctuations in Parkinson's disease. Delphi consensus of a group of experts in movement disorders]. Rev Neurol 2020; 71:407-420. [PMID: 33205387 DOI: 10.33588/rn.7111.2020088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
INTRODUCTION Motor fluctuations are one of the most common complications of Parkinson's disease and their treatment is still a complex matter. Therefore, from the Neurology Movement Disorders Group we present our clinical experience in the treatment of these complications, with the intention of it being useful in decision-making in daily clinical practice. DEVELOPMENT Nineteen questions were developed based on a literature review and an open survey answered by members of this group. These issues were discussed in two phases, using the Delphi methodology. Considering the results of the survey, levodopa dose adjustment and dopamine agonists are the option with the best efficacy/tolerability ratio in the treatment of motor fluctuations. Rotigotine is useful in the motor fluctuations associated with gastroparesis, and intermittent subcutaneous apomorphine has positive effects in patients with unpredictable off periods. The most relevant adverse effect associated with dopamine agonists is impulse control disorder. Catechol-O-methyltransferase inhibitors are useful in the initial stages of motor fluctuations, especially in wearing off. Monoamine oxidase inhibitors are generally drugs that are well-tolerated and useful in motor fluctuations. If these measures are not effective, second-line treatments should be indicated on a case-by-case basis. CONCLUSION The clinical profile of patients with Parkinson's disease is paramount in deciding the most appropriate therapy for the treatment of motor fluctuations.
Collapse
Affiliation(s)
| | | | | | | | | | - M J Catalán
- Hospital Universitario Clínico San Carlos, Madrid, España
| | | | | | - R García-Ramos
- Hospital Universitario Clínico San Carlos, Madrid, España
| | | | | | | | - J J López-Lozano
- Hospital Universitario Puerta de Hierro-Majadahonda, 28035 Majadahonda, España
| | | | | | | | - M Mata
- Hospital Universitario Infanta Sofía, Madrid, España
| | | | - I J Posada
- Hospital Universitario 12 de Octubre, Madrid, España
| | - A Rojo
- Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, España
| | | | - C Ruiz-Huete
- Hospital Nuestra Señora del Rosario, Madrid, España
| | - M P Sánchez-Alonso
- Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, España
| | | | | |
Collapse
|
6
|
García-Ramos R, Santos-García D, Alonso-Cánovas A, Álvarez-Sauco M, Ares B, Ávila A, Caballol N, Carrillo F, Escamilla Sevilla F, Freire E, Gómez Esteban JC, Legarda I, López Manzanares L, López Valdés E, Martínez-Torres I, Mata M, Pareés I, Pascual-Sedano B, Martínez Castrillo JC, Mir P. Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2. Neurologia 2020; 36:159-168. [PMID: 32980194 DOI: 10.1016/j.nrl.2020.05.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2020] [Accepted: 05/05/2020] [Indexed: 10/23/2022] Open
Abstract
INTRODUCTION Many diseases associated with hyperkinetic movement disorders manifest in women of childbearing age. It is important to understand the risks of these diseases during pregnancy, and the potential risks of treatment for the fetus. OBJECTIVES This study aims to define the clinical characteristics and the factors affecting the lives of women of childbearing age with dystonia, chorea, Tourette syndrome, tremor, and restless legs syndrome, and to establish guidelines for management of pregnancy and breastfeeding in these patients. RESULTS This consensus document was developed through an exhaustive literature search and a discussion of the content by a group of movement disorder experts from the Spanish Society of Neurology. CONCLUSIONS We must evaluate the risks and benefits of treatment in all women with hyperkinetic movement disorders, whether pre-existing or with onset during pregnancy, and aim to reduce effective doses as much as possible or to administer drugs only when necessary. In hereditary diseases, families should be offered genetic counselling. It is important to recognise movement disorders triggered during pregnancy, such as certain types of chorea and restless legs syndrome.
Collapse
Affiliation(s)
- R García-Ramos
- Instituto de Investigación Sanitaria San Carlos (IdISCC), Hospital Clínico San Carlos, Madrid, España.
| | - D Santos-García
- Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, España
| | | | - M Álvarez-Sauco
- Hospital General Universitario de Elche, Elche, Alicante, España
| | - B Ares
- Hospital Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España
| | - A Ávila
- Consorci Sanitari Integral, Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, España; Consorci Sanitari Integral, Hospital Sant Joan Despí Moisés Broggi, Sant Joan Despí, Barcelona, España
| | - N Caballol
- Consorci Sanitari Integral, Hospital Sant Joan Despí Moisés Broggi, Sant Joan Despí, Barcelona, España
| | - F Carrillo
- Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, España; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, España
| | - F Escamilla Sevilla
- Instituto de Investigación Biosanitaria (IBS), Hospital Universitario Virgen de las Nieves, Granada, España
| | - E Freire
- Hospital General Universitario de Elche, Elche, Alicante, España; Hospital IMED Elche, Elche, Alicante, España
| | | | - I Legarda
- Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, España
| | | | - E López Valdés
- Instituto de Investigación Sanitaria San Carlos (IdISCC), Hospital Clínico San Carlos, Madrid, España
| | | | - M Mata
- Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, España
| | - I Pareés
- Hospital Universitario Ramón y Cajal, Madrid, España; Hospital Rúber Internacional, Madrid, España
| | - B Pascual-Sedano
- Estudios de Ciencias de la Salud, Hospital Santa Creu i Sant Pau, Barcelona, España; Universitat Oberta de Catalunya (UOC), Barcelona, España; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, España
| | | | - P Mir
- Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, España; Hospital Rúber Internacional, Madrid, España
| |
Collapse
|
7
|
Garcia-Rodriguez J, Fernandez-Gomez J, Cozar J, Miñana B, Gomez-Veiga F, Rodriguez-Antolin A, Pórtela P, Blanco E, González J, Baena V, Morales P, Villavicencio H, Palou J, Loizaga A, Ciudin A, Mihai D, Martínez Jabaloyas J, Castelló A, Díez N, Romero F, Subirá J, Chávez A, Capapé V, Mata M, Elizalde J, Lobato J, Jiménez J, Pérez Llorca L, Tenza J, Herranz F, Husillos A, López E, Ramírez D, Blaha I, Izquierdo E, Reina L, Passas J, Díez L, Hevia M, Castells M, Concepción Masip T, Plata A, Asuar Aydillo S, Alonso J, Mateos J, Carballido J, Martínez C, Areche J, Rodríguez R, Hevia V, Álvarez S, Requena M, Prieto R, Carazo J, Márquez J, Gómez E, García J, Amón J, Cepeda M, Álvarez L, Rodríguez V, de la Cruz B, Rivero A, Sánchez J, Mainez J, Medina R, Conde M, Castiñeiras J, González Baena A, Sánchez E, Campanario R, Saiz R, Romero E, Morote J, Raventós C, Celma A, Vázquez F, Gómez A, Buendía E, García N. Androgen deprivation therapy in patients with localized disease: Comparison with curative intent treatments and time to castration resistance. Results of the Spanish Prostate Cancer Registry. Actas Urol Esp 2020; 44:156-163. [PMID: 32113829 DOI: 10.1016/j.acuro.2019.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2018] [Revised: 03/26/2019] [Accepted: 06/09/2019] [Indexed: 10/24/2022]
Abstract
BACKGROUND The effect of primary androgen deprivation therapy (ADT) in patients with localized prostate cancer (PCa) has not been well documented. The objective of the present study was to analyze the outcome of tumors treated with ADT as primary therapy in the Spanish Prostate Cancer Registry (19.4% of the series). PATIENTS AND METHODS Patients were classified in three groups: 1) with low/intermediate risk clinically localized tumors; 2) with high risk and locally advanced (T3-4) tumors; 3) with metastatic tumors. Time to castration resistance and overall cancer-specific survival were analyzed. In non-metastatic tumors, survivals in patients treated with ADT were compared with data from patients who underwent local treatments from the Spanish Prostate Cancer Registry. RESULTS 703 cases were analyzed. There were significant differences in the time to castration resistance, which was lower in the group of metastatic tumors. During follow-up, there were 179 deaths (25.5%) of which 89 (12.6%) were due to PCa. After 3 years of ADT, only 14.6% of patients in group 1 had died (1% due to PCa), 20.5% in group 2 and 46.8% in group 3 (9.2% and 31.3% due to PCa, respectively). Cancer-specific survival was significantly worse in group 1 using ADT than radical prostatectomy or radiotherapy. In high-risk and locally advanced tumors, ADT also had a lower cancer-specific survival than local treatments. CONCLUSION A longer time until the castration resistance was observed in patients with well- and intermediate-risk localized tumors treated with ADT. Patients with metastatic tumors showed the shortest time to castration resistance.
Collapse
|
8
|
Crous PW, Wingfield MJ, Lombard L, Roets F, Swart WJ, Alvarado P, Carnegie AJ, Moreno G, Luangsaard J, Thangavel R, Alexandrova AV, Baseia IG, Bellanger JM, Bessette AE, Bessette AR, De la Peña-Lastra S, García D, Gené J, Pham THG, Heykoop M, Malysheva E, Malysheva V, Martín MP, Morozova OV, Noisripoom W, Overton BE, Rea AE, Sewall BJ, Smith ME, Smyth CW, Tasanathai K, Visagie CM, Adamčík S, Alves A, Andrade JP, Aninat MJ, Araújo RVB, Bordallo JJ, Boufleur T, Baroncelli R, Barreto RW, Bolin J, Cabero J, Caboň M, Cafà G, Caffot MLH, Cai L, Carlavilla JR, Chávez R, de Castro RRL, Delgat L, Deschuyteneer D, Dios MM, Domínguez LS, Evans HC, Eyssartier G, Ferreira BW, Figueiredo CN, Liu F, Fournier J, Galli-Terasawa LV, Gil-Durán C, Glienke C, Gonçalves MFM, Gryta H, Guarro J, Himaman W, Hywel-Jones N, Iturrieta-González I, Ivanushkina NE, Jargeat P, Khalid AN, Khan J, Kiran M, Kiss L, Kochkina GA, Kolařík M, Kubátová A, Lodge DJ, Loizides M, Luque D, Manjón JL, Marbach PAS, Massola NS, Mata M, Miller AN, Mongkolsamrit S, Moreau PA, Morte A, Mujic A, Navarro-Ródenas A, Németh MZ, Nóbrega TF, Nováková A, Olariaga I, Ozerskaya SM, Palma MA, Petters-Vandresen DAL, Piontelli E, Popov ES, Rodríguez A, Requejo Ó, Rodrigues ACM, Rong IH, Roux J, Seifert KA, Silva BDB, Sklenář F, Smith JA, Sousa JO, Souza HG, De Souza JT, Švec K, Tanchaud P, Tanney JB, Terasawa F, Thanakitpipattana D, Torres-Garcia D, Vaca I, Vaghefi N, van Iperen AL, Vasilenko OV, Verbeken A, Yilmaz N, Zamora JC, Zapata M, Jurjević Ž, Groenewald JZ. Fungal Planet description sheets: 951-1041. Persoonia 2019; 43:223-425. [PMID: 32214501 PMCID: PMC7085856 DOI: 10.3767/persoonia.2019.43.06] [Citation(s) in RCA: 80] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/01/2019] [Accepted: 10/09/2019] [Indexed: 11/25/2022]
Abstract
Novel species of fungi described in this study include those from various countries as follows: Antarctica, Apenidiella antarctica from permafrost, Cladosporium fildesense from an unidentified marine sponge. Argentina, Geastrum wrightii on humus in mixed forest. Australia, Golovinomyces glandulariae on Glandularia aristigera, Neoanungitea eucalyptorum on leaves of Eucalyptus grandis, Teratosphaeria corymbiicola on leaves of Corymbia ficifolia, Xylaria eucalypti on leaves of Eucalyptus radiata. Brazil, Bovista psammophila on soil, Fusarium awaxy on rotten stalks of Zea mays, Geastrum lanuginosum on leaf litter covered soil, Hermetothecium mikaniae-micranthae (incl. Hermetothecium gen. nov.) on Mikania micrantha, Penicillium reconvexovelosoi in soil, Stagonosporopsis vannaccii from pod of Glycine max. British Virgin Isles, Lactifluus guanensis on soil. Canada, Sorocybe oblongispora on resin of Picea rubens. Chile, Colletotrichum roseum on leaves of Lapageria rosea. China, Setophoma caverna from carbonatite in Karst cave. Colombia, Lareunionomyces eucalypticola on leaves of Eucalyptus grandis. Costa Rica, Psathyrella pivae on wood. Cyprus, Clavulina iris on calcareous substrate. France, Chromosera ambigua and Clavulina iris var. occidentalis on soil. French West Indies, Helminthosphaeria hispidissima on dead wood. Guatemala, Talaromyces guatemalensis in soil. Malaysia, Neotracylla pini (incl. Tracyllales ord. nov. and Neotracylla gen. nov.) and Vermiculariopsiella pini on needles of Pinus tecunumanii. New Zealand, Neoconiothyrium viticola on stems of Vitis vinifera, Parafenestella pittospori on Pittosporum tenuifolium, Pilidium novae-zelandiae on Phoenix sp. Pakistan, Russula quercus-floribundae on forest floor. Portugal, Trichoderma aestuarinum from saline water. Russia, Pluteus liliputianus on fallen branch of deciduous tree, Pluteus spurius on decaying deciduous wood or soil. South Africa, Alloconiothyrium encephalarti, Phyllosticta encephalarticola and Neothyrostroma encephalarti (incl. Neothyrostroma gen. nov.) on leaves of Encephalartos sp., Chalara eucalypticola on leaf spots of Eucalyptus grandis × urophylla, Clypeosphaeria oleae on leaves of Olea capensis, Cylindrocladiella postalofficium on leaf litter of Sideroxylon inerme, Cylindromonium eugeniicola (incl. Cylindromonium gen. nov.) on leaf litter of Eugenia capensis, Cyphellophora goniomatis on leaves of Gonioma kamassi, Nothodactylaria nephrolepidis (incl. Nothodactylaria gen. nov. and Nothodactylariaceae fam. nov.) on leaves of Nephrolepis exaltata, Falcocladium eucalypti and Gyrothrix eucalypti on leaves of Eucalyptus sp., Gyrothrix oleae on leaves of Olea capensis subsp. macrocarpa, Harzia metrosideri on leaf litter of Metrosideros sp., Hippopotamyces phragmitis (incl. Hippopotamyces gen. nov.) on leaves of Phragmites australis, Lectera philenopterae on Philenoptera violacea, Leptosillia mayteni on leaves of Maytenus heterophylla, Lithohypha aloicola and Neoplatysporoides aloes on leaves of Aloe sp., Millesimomyces rhoicissi (incl. Millesimomyces gen. nov.) on leaves of Rhoicissus digitata, Neodevriesia strelitziicola on leaf litter of Strelitzia nicolai, Neokirramyces syzygii (incl. Neokirramyces gen. nov.) on leaf spots of Syzygium sp., Nothoramichloridium perseae (incl. Nothoramichloridium gen. nov. and Anungitiomycetaceae fam. nov.) on leaves of Persea americana, Paramycosphaerella watsoniae on leaf spots of Watsonia sp., Penicillium cuddlyae from dog food, Podocarpomyces knysnanus (incl. Podocarpomyces gen. nov.) on leaves of Podocarpus falcatus, Pseudocercospora heteropyxidicola on leaf spots of Heteropyxis natalensis, Pseudopenidiella podocarpi, Scolecobasidium podocarpi and Ceramothyrium podocarpicola on leaves of Podocarpus latifolius, Scolecobasidium blechni on leaves of Blechnum capense, Stomiopeltis syzygii on leaves of Syzygium chordatum, Strelitziomyces knysnanus (incl. Strelitziomyces gen. nov.) on leaves of Strelitzia alba, Talaromyces clemensii from rotting wood in goldmine, Verrucocladosporium visseri on Carpobrotus edulis. Spain, Boletopsis mediterraneensis on soil, Calycina cortegadensisi on a living twig of Castanea sativa, Emmonsiellopsis tuberculata in fluvial sediments, Mollisia cortegadensis on dead attached twig of Quercus robur, Psathyrella ovispora on soil, Pseudobeltrania lauri on leaf litter of Laurus azorica, Terfezia dunensis in soil, Tuber lucentum in soil, Venturia submersa on submerged plant debris. Thailand, Cordyceps jakajanicola on cicada nymph, Cordyceps kuiburiensis on spider, Distoseptispora caricis on leaves of Carex sp., Ophiocordyceps khonkaenensis on cicada nymph. USA, Cytosporella juncicola and Davidiellomyces juncicola on culms of Juncus effusus, Monochaetia massachusettsianum from air sample, Neohelicomyces melaleucae and Periconia neobrittanica on leaves of Melaleuca styphelioides × lanceolata, Pseudocamarosporium eucalypti on leaves of Eucalyptus sp., Pseudogymnoascus lindneri from sediment in a mine, Pseudogymnoascus turneri from sediment in a railroad tunnel, Pulchroboletus sclerotiorum on soil, Zygosporium pseudomasonii on leaf of Serenoa repens. Vietnam, Boletus candidissimus and Veloporphyrellus vulpinus on soil. Morphological and culture characteristics are supported by DNA barcodes.
Collapse
Affiliation(s)
- P W Crous
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), Faculty of Natural and Agricultural Sciences, University of Pretoria, Private Bag X20, Hatfield 0028, Pretoria, South Africa
| | - M J Wingfield
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), Faculty of Natural and Agricultural Sciences, University of Pretoria, Private Bag X20, Hatfield 0028, Pretoria, South Africa
| | - L Lombard
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
| | - F Roets
- Department of Conservation Ecology and Entomology, Stellenbosch University, Stellenbosch 7600, South Africa
| | - W J Swart
- Department of Plant Sciences (Division of Plant Pathology), University of the Free State, P.O. Box 339, Bloemfontein 9300, South Africa
| | - P Alvarado
- ALVALAB, La Rochela 47, 39012 Santander, Spain
| | - A J Carnegie
- Forest Health & Biosecurity, Forest Science, NSW Department of Primary Industries, Level 12, 10 Valentine Ave, Parramatta NSW 2150, Australia
| | - G Moreno
- Departamento de Ciencias de la Vida (Área de Botánica), Facultad de Ciencias, Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain
| | - J Luangsaard
- National Center for Genetic Engineering and Biotechnology (BIOTEC), 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand
| | - R Thangavel
- Plant Health and Environment Laboratory, Ministry for Primary Industries, P.O. Box 2095, Auckland 1140, New Zealand
| | - A V Alexandrova
- Lomonosov Moscow State University (MSU), Faculty of Biology, 119234, 1, 12 Leninskie Gory Str., Moscow, Russia
- Joint Russian-Vietnamese Tropical Research and Technological Center, Hanoi, Vietnam
- Peoples' Friendship University of Russia (RUDN University) 6 Miklouho-Maclay Str., 117198, Moscow, Russia
| | - I G Baseia
- Departamento Botânica e Zoologia, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Campus Universitário, 59072-970 Natal, RN, Brazil
| | - J-M Bellanger
- CEFE, CNRS, Université de Montpellier, Université Paul-Valéry Montpellier 3, EPHE, IRD, INSERM, 1919 route de Mende, F-34293 Montpellier Cedex 5, France
| | | | | | - S De la Peña-Lastra
- Departamento de Edafoloxía e Química Agrícola, Facultade de Biología, Universidade de Santiago de Compostela, 15782-Santiago de Compostela, Spain
| | - D García
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain
| | - J Gené
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain
| | - T H G Pham
- Joint Russian-Vietnamese Tropical Research and Technological Center, Hanoi, Vietnam
- Saint Petersburg State Forestry University, 194021, 5U Institutsky Str., Saint Petersburg, Russia
| | - M Heykoop
- Departamento de Ciencias de la Vida (Área de Botánica), Facultad de Ciencias, Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain
| | - E Malysheva
- Komarov Botanical Institute of the Russian Academy of Sciences, Prof. Popov Str. 2, RUS-197376, Saint Petersburg, Russia
| | - V Malysheva
- Komarov Botanical Institute of the Russian Academy of Sciences, Prof. Popov Str. 2, RUS-197376, Saint Petersburg, Russia
| | - M P Martín
- Real Jardín Botánico RJB-CSIC, Plaza de Murillo 2, 28014 Madrid, Spain
| | - O V Morozova
- Joint Russian-Vietnamese Tropical Research and Technological Center, Hanoi, Vietnam
- Komarov Botanical Institute of the Russian Academy of Sciences, Prof. Popov Str. 2, RUS-197376, Saint Petersburg, Russia
| | - W Noisripoom
- National Center for Genetic Engineering and Biotechnology (BIOTEC), 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand
| | - B E Overton
- Department of Biology, 205 East Campus Science Center, Lock Haven University, Lock Haven, PA 17745 USA
| | - A E Rea
- Department of Biology, 205 East Campus Science Center, Lock Haven University, Lock Haven, PA 17745 USA
| | - B J Sewall
- Department of Biology, 1900 North 12th Street, Temple University, Philadelphia, PA 19122 USA
| | - M E Smith
- Department of Plant Pathology & Florida Museum of Natural History, 2527 Fifield Hall, Gainesville FL 32611, USA
| | - C W Smyth
- Department of Biology, 205 East Campus Science Center, Lock Haven University, Lock Haven, PA 17745 USA
| | - K Tasanathai
- National Center for Genetic Engineering and Biotechnology (BIOTEC), 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand
| | - C M Visagie
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), Faculty of Natural and Agricultural Sciences, University of Pretoria, Private Bag X20, Hatfield 0028, Pretoria, South Africa
- Biosystematics Division, Agricultural Research Council - Plant Health and Protection, P. Bag X134, Queenswood, Pretoria 0121, South Africa
| | - S Adamčík
- Institute of Botany, Plant Science and Biodiversity Centre, Slovak Academy of Sciences, Dúbravská cesta 9, SK-84523, Bratislava, Slovakia
| | - A Alves
- Departamento de Biologia, CESAM, Universidade de Aveiro, 3810-193 Aveiro, Portugal
| | - J P Andrade
- Universidade Estadual de Feira de Santana, Bahia, Brazil and Faculdades Integradas de Sergipe, Sergipe, Brazil
| | - M J Aninat
- Servicio Agrícola y Ganadero, Laboratorio Regional Valparaíso, Unidad de Fitopatología, Antonio Varas 120, Valparaíso, Código Postal 2360451, Chile
| | - R V B Araújo
- Instituto de Biologia, Universidade Federal da Bahia, Salvador, Bahia, Brazil
| | - J J Bordallo
- Laboratorio de Investigacion, San Vicente Raspeig, 03690 Alicante, Spain
| | - T Boufleur
- Departamento de Fitopatologia e Nematologia, Escola Superior de Agricultura "Luiz de Queiroz", Universidade de São Paulo, Caixa Postal 09, CEP 13418-900, Piracicaba-SP, Brazil
| | - R Baroncelli
- Instituto Hispano-Luso de Investigaciones Agrarias (CIALE), University of Salamanca, Calle del Duero, 12; 37185 Villamayor (Salamanca), Spain
| | - R W Barreto
- Departamento de Fitopatologia, Universidade Federal de Viçosa, Viçosa, 36570-900, MG, Brazil
| | - J Bolin
- 7340 Viale Sonata, Lake Worth, FL 33467, USA
| | - J Cabero
- Asociación Micológica Zamorana, 49080 Zamora, Spain
| | - M Caboň
- Institute of Botany, Plant Science and Biodiversity Centre, Slovak Academy of Sciences, Dúbravská cesta 9, SK-84523, Bratislava, Slovakia
| | - G Cafà
- CABI Europe-UK, Bakeham Lane, Egham, Surrey TW20 9TY, UK
| | - M L H Caffot
- Instituto de Ecorregiones Andinas (INECOA), CONICET-Universidad Nacional de Jujuy, CP 4600, San Salvador de Jujuy, Jujuy, Argentina
| | - L Cai
- State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China
| | - J R Carlavilla
- Departamento de Ciencias de la Vida (Área de Botánica), Facultad de Ciencias, Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain
| | - R Chávez
- Facultad de Química y Biología, Universidad de Santiago de Chile (USACH), Alameda 3363, Estación Central, 917002, Santiago, Chile
| | - R R L de Castro
- Departamento de Fitopatologia e Nematologia, Escola Superior de Agricultura "Luiz de Queiroz", Universidade de São Paulo, Caixa Postal 09, CEP 13418-900, Piracicaba-SP, Brazil
| | - L Delgat
- Department of Biology, Ghent University, Karel Lodewijk Ledeganckstraat 35, Ghent, Belgium
| | | | - M M Dios
- Departamento de Biología, Facultad de Ciencias Exactas y Naturales, Universidad Nacional de Catamarca, Av. Belgrano 300, San Fernando del Valle de Catamarca, Catamarca, Argentina
| | - L S Domínguez
- Laboratorio de Micología, Instituto Multidisciplinario de Biología Vegetal, CONICET, Universidad Nacional de Córdoba, CC 495, 5000, Córdoba, Argentina
| | - H C Evans
- CAB International, UK Centre, Egham, Surrey TW20 9TY, UK
| | - G Eyssartier
- Attaché honoraire au Muséum national d'histoire naturelle de Paris, 180 allée du Château, F-24660 Sanilhac, France
| | - B W Ferreira
- Departamento de Fitopatologia, Universidade Federal de Viçosa, Viçosa, 36570-900, MG, Brazil
| | | | - F Liu
- State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China
| | | | | | - C Gil-Durán
- Facultad de Química y Biología, Universidad de Santiago de Chile (USACH), Alameda 3363, Estación Central, 917002, Santiago, Chile
| | - C Glienke
- Federal University of Paraná, Curitiba, Brazil
| | - M F M Gonçalves
- Departamento de Biologia, CESAM, Universidade de Aveiro, 3810-193 Aveiro, Portugal
| | - H Gryta
- Université Paul Sabatier, CNRS, IRD, UMR5174 EDB (Laboratoire Évolution et Diversité Biologique), 118 route de Narbonne, F-31062 Toulouse, France
| | - J Guarro
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain
| | - W Himaman
- Forest Entomology and Microbiology Research Group, Department of National Parks, Wildlife and Plant Conservation, 61 Phaholyothin Road, Chatuchak, Bangkok 10900, Thailand
| | - N Hywel-Jones
- BioAsia Life Sciences Institute, 1938 Xinqun Rd, Pinghu, Zhejiang 314200, PR China
| | - I Iturrieta-González
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain
| | - N E Ivanushkina
- All-Russian collection of microorganisms (VKM), IBPM RAS, prospect Nauki, 5, Pushchino, Moscow Region, Russia
| | - P Jargeat
- Université Paul Sabatier, CNRS, IRD, UMR5174 EDB (Laboratoire Évolution et Diversité Biologique), 118 route de Narbonne, F-31062 Toulouse, France
| | - A N Khalid
- Department of Botany, University of Punjab, Quaid e Azam campus, Lahore 54590, Pakistan
| | - J Khan
- Center for Plant Sciences and Biodiversity, University of Swat, KP, Pakistan
| | - M Kiran
- Department of Botany, University of Punjab, Quaid e Azam campus, Lahore 54590, Pakistan
| | - L Kiss
- Centre for Crop Health, University of Southern Queensland, Toowoomba 4350, Queensland, Australia
| | - G A Kochkina
- All-Russian collection of microorganisms (VKM), IBPM RAS, prospect Nauki, 5, Pushchino, Moscow Region, Russia
| | - M Kolařík
- Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology of the CAS, v.v.i., Vídeňská 1083, 142 20 Prague 4, Czech Republic
- Department of Botany, Faculty of Science, Charles University, Benátská 2, 12801 Prague 2, Czech Republic
| | - A Kubátová
- Department of Botany, Faculty of Science, Charles University, Benátská 2, 12801 Prague 2, Czech Republic
| | - D J Lodge
- Department of Plant Pathology, 2105 Miller Plant Sciences Bldg., University of Georgia, Athens, GA 30606, USA
| | | | - D Luque
- C/Severo Daza 31, 41820 Carrión de los Céspedes (Sevilla), Spain
| | - J L Manjón
- Departamento de Ciencias de la Vida (Área de Botánica), Facultad de Ciencias, Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain
| | - P A S Marbach
- Federal University of Recôncavo da Bahia, Bahia, Brazil
| | - N S Massola
- Departamento de Fitopatologia e Nematologia, Escola Superior de Agricultura "Luiz de Queiroz", Universidade de São Paulo, Caixa Postal 09, CEP 13418-900, Piracicaba-SP, Brazil
| | - M Mata
- Departamento de Ciencias de la Vida (Área de Botánica), Facultad de Ciencias, Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain
| | - A N Miller
- University of Illinois Urbana-Champaign, Illinois Natural History Survey, 1816 South Oak Street, Champaign, Illinois, 61820, USA
| | - S Mongkolsamrit
- National Center for Genetic Engineering and Biotechnology (BIOTEC), 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand
| | - P-A Moreau
- Université de Lille, Faculté de pharmacie de Lille, EA 4483, F-59000 Lille, France
| | - A Morte
- Departamento de Biología Vegetal (Botánica), Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain
| | - A Mujic
- Department of Biology, Fresno State University, 2555 East San Ramon Ave, Fresno CA 93740, USA
| | - A Navarro-Ródenas
- Departamento de Biología Vegetal (Botánica), Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain
| | - M Z Németh
- Plant Protection Institute, Centre for Agricultural Research, Hungarian Academy of Sciences, Budapest H-1022, Herman Otto út 15, Hungary
| | - T F Nóbrega
- Departamento de Fitopatologia, Universidade Federal de Viçosa, Viçosa, 36570-900, MG, Brazil
| | - A Nováková
- Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology of the CAS, v.v.i., Vídeňská 1083, 142 20 Prague 4, Czech Republic
| | - I Olariaga
- Biology and Geology Physics and Inorganic Chemistry Department, Rey Juan Carlos university, C/Tulipán s/n, 28933 Móstoles, Madrid, Spain
| | - S M Ozerskaya
- All-Russian collection of microorganisms (VKM), IBPM RAS, prospect Nauki, 5, Pushchino, Moscow Region, Russia
| | - M A Palma
- Servicio Agrícola y Ganadero, Laboratorio Regional Valparaíso, Unidad de Fitopatología, Antonio Varas 120, Valparaíso, Código Postal 2360451, Chile
| | | | - E Piontelli
- Universidad de Valparaíso, Facultad de Medicina, Profesor Emérito Cátedra de Micología, Angámos 655, Reñaca, Viña del Mar, Código Postal 2540064, Chile
| | - E S Popov
- Joint Russian-Vietnamese Tropical Research and Technological Center, Hanoi, Vietnam
- Komarov Botanical Institute of the Russian Academy of Sciences, Prof. Popov Str. 2, RUS-197376, Saint Petersburg, Russia
| | - A Rodríguez
- Departamento de Biología Vegetal (Botánica), Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain
| | - Ó Requejo
- Grupo Micológico Gallego, San Xurxo, A Laxe 12b, 36470, Salceda de Caseleas, Spain
| | - A C M Rodrigues
- Programa de Pós-Graduação em Biologia de Fungos, Departamento de Micologia, Universidade Federal de Pernambuco, 50670-420 Recife, PE, Brazil
| | - I H Rong
- Biosystematics Division, Agricultural Research Council - Plant Health and Protection, P. Bag X134, Queenswood, Pretoria 0121, South Africa
| | - J Roux
- Department of Plant and Soil Sciences, Forestry and Agricultural Biotechnology Institute (FABI), Faculty of Natural and Agricultural Sciences, University of Pretoria, Private Bag X20, Hatfield 0028, Pretoria, South Africa
| | - K A Seifert
- Biodiversity (Mycology), Agriculture and Agri-Food Canada, 960 Carling Avenue, Ottawa, ON K1A 0C6, Canada
| | - B D B Silva
- Instituto de Biologia, Universidade Federal da Bahia, Salvador, Bahia, Brazil
| | - F Sklenář
- Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology of the CAS, v.v.i., Vídeňská 1083, 142 20 Prague 4, Czech Republic
- Department of Botany, Faculty of Science, Charles University, Benátská 2, 12801 Prague 2, Czech Republic
| | - J A Smith
- School of Forest Resources and Conservation, University of Florida, Gainesville, Florida 32611-0680, USA
| | - J O Sousa
- Departamento Botânica e Zoologia, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Campus Universitário, 59072-970 Natal, RN, Brazil
| | - H G Souza
- Federal University of Recôncavo da Bahia, Bahia, Brazil
| | - J T De Souza
- Federal University of Lavras, Minas Gerais, Brazil
| | - K Švec
- Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology of the CAS, v.v.i., Vídeňská 1083, 142 20 Prague 4, Czech Republic
- Department of Botany, Faculty of Science, Charles University, Benátská 2, 12801 Prague 2, Czech Republic
| | - P Tanchaud
- 2 rue des Espics, F-17250 Soulignonne, France
| | - J B Tanney
- Pacific Forestry Centre, Canadian Forest Service, Natural Resources Canada, 506 Burnside Road, Victoria, BC V8Z 1M5, Canada
| | - F Terasawa
- Federal University of Paraná, Curitiba, Brazil
| | - D Thanakitpipattana
- National Center for Genetic Engineering and Biotechnology (BIOTEC), 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand
| | - D Torres-Garcia
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain
| | - I Vaca
- Facultad de Ciencias, Universidad de Chile, Las Palmeras 3425, Ñuñoa, Santiago, Chile
| | - N Vaghefi
- Centre for Crop Health, University of Southern Queensland, Toowoomba 4350, Queensland, Australia
| | - A L van Iperen
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
| | - O V Vasilenko
- All-Russian collection of microorganisms (VKM), IBPM RAS, prospect Nauki, 5, Pushchino, Moscow Region, Russia
| | - A Verbeken
- Department of Biology, Ghent University, Karel Lodewijk Ledeganckstraat 35, Ghent, Belgium
| | - N Yilmaz
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), Faculty of Natural and Agricultural Sciences, University of Pretoria, Private Bag X20, Hatfield 0028, Pretoria, South Africa
| | - J C Zamora
- Museum of Evolution, Uppsala University, Norbyvägen 16, SE-75236 Uppsala, Sweden
- Departamento de Biología Vegetal II, Facultad de Farmacia, Universidad Complutense de Madrid, Ciudad Universitaria, plaza de Ramón y Cajal s/n, E-28040, Madrid, Spain
| | - M Zapata
- Servicio Agrícola y Ganadero, Laboratorio Regional Chillán, Unidad de Fitopatología, Claudio Arrau 738, Chillán, Código Postal 3800773, Chile
| | - Ž Jurjević
- EMSL Analytical, Inc., 200 Route 130 North, Cinnaminson, NJ 08077, USA
| | - J Z Groenewald
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
| |
Collapse
|
9
|
Santos García D, de Deus Fonticoba T, Suárez Castro E, Borrué C, Mata M, Solano Vila B, Cots Foraster A, Álvarez Sauco M, Rodríguez Pérez AB, Vela L, Macías Y, Escalante S, Esteve P, Reverté Villarroya S, Cubo E, Casas E, Arnaiz S, Carrillo Padilla F, Pueyo Morlans M, Mir P, Martinez-Martin P. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort. Parkinsonism Relat Disord 2019; 66:151-157. [PMID: 31409572 DOI: 10.1016/j.parkreldis.2019.07.031] [Citation(s) in RCA: 52] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/12/2018] [Revised: 01/18/2019] [Accepted: 07/27/2019] [Indexed: 11/28/2022]
Abstract
OBJECTIVE To identify factors related to a poor health-related and global quality of life (QoL) in a cohort of non-demented Parkinson's disease (PD) patients and compare to a control group. METHODS The data correspond to the baseline evaluation of the COPPADIS-2015 Study, an observational, 5-year follow-up, multicenter, evaluation study. Three instruments were used to assess QoL: (1) the 39-item Parkinson's disease Questionnaire (PDQ-39), (2) a subjective rating of global QoL (PQ-10), and (3) the EUROHIS-QOL 8-item index (EUROHIS-QOL8). Multiple linear regression methods were used to evaluate the direct impact of different variables on these QoL measures. RESULTS QoL was worse in PD patients (n = 692; 62.6 ± 8.9 years old, 60.3% males) than controls (n = 206; 61 ± 8.3 years old, 49.5% males): PDQ-39, 17.1 ± 13.5 vs 4.4 ± 6.3 (p < 0.0001); PQ-10, 7.3 ± 1.6 vs 8.1 ± 1.2 (p < 0.0001); EUROHIS-QOL8, 3.8 ± 0.6 vs 4.2 ± 0.5 (p < 0.0001). A high correlation was observed between PDQ-39 and Non-Motor Symptoms Scale (NMSS) (r = 0.72; p < 0.0001), and PDQ-39 and Beck Depression Inventory-II (BDI-II) (r = 0.65; p < 0.0001). For health-related QoL (PDQ-39), non-motor symptoms burden (NMSS), mood (BDI-II), and gait problems (Freezing Of Gait Questionnaire [FOGQ]) provided the highest contribution to the model (β = 0.32, 0.28, and 0.27, respectively; p < 0.0001); whereas mood and gait problems contributed the most to global QoL (PQ-10, β = -0.46 and -0.21, respectively; EUROHIS-QOL8, β = -0.44 and -0.23, respectively). CONCLUSIONS QoL is worse in PD patients than in controls. Mood, non-motor symptoms burden, and gait problems seem to be the most relevant factors affecting health-related and global perceived QoL in non-demented PD patients.
Collapse
Affiliation(s)
- D Santos García
- Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain; Hospital Arquitecto Marcide y Hospital Naval, Complejo Hospitalario Universitario de Ferrol (CHUF), Ferrol, A Coruña, Spain.
| | - T de Deus Fonticoba
- Hospital Arquitecto Marcide y Hospital Naval, Complejo Hospitalario Universitario de Ferrol (CHUF), Ferrol, A Coruña, Spain
| | - E Suárez Castro
- Hospital Arquitecto Marcide y Hospital Naval, Complejo Hospitalario Universitario de Ferrol (CHUF), Ferrol, A Coruña, Spain
| | - C Borrué
- Hospital Infanta Sofía, Madrid, Spain
| | - M Mata
- Hospital Infanta Sofía, Madrid, Spain
| | - B Solano Vila
- Institut d'Assistència Sanitària (IAS) - Institut Cátala de la Salud, Girona, Spain
| | - A Cots Foraster
- Institut d'Assistència Sanitària (IAS) - Institut Cátala de la Salud, Girona, Spain
| | | | | | - L Vela
- Fundación Hospital de Alcorcón, Madrid, Spain; CINAC (Centro Integral de Neurociencias A. C.), Hospital HM Puerta del Sur, Móstoles, Madrid, Spain
| | - Y Macías
- Fundación Hospital de Alcorcón, Madrid, Spain
| | - S Escalante
- Hospital de Tortosa Verge de la Cinta (HTVC), Tortosa, Tarragona, Spain
| | - P Esteve
- Hospital de Tortosa Verge de la Cinta (HTVC), Tortosa, Tarragona, Spain
| | | | - E Cubo
- Complejo Asistencial Universitario de Burgos, Burgos, Spain
| | - E Casas
- Complejo Asistencial Universitario de Burgos, Burgos, Spain
| | - S Arnaiz
- Complejo Asistencial Universitario de Burgos, Burgos, Spain
| | - F Carrillo Padilla
- Hospital Universitario de Canarias, San Cristóbal de la Laguna, Santa Cruz de Tenerife, Spain
| | - M Pueyo Morlans
- Hospital Universitario de Canarias, San Cristóbal de la Laguna, Santa Cruz de Tenerife, Spain
| | - P Mir
- Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain
| | - P Martinez-Martin
- Centro Nacional de Epidemiología y CIBERNED, Instituto de Salud Carlos III, Madrid, Spain
| | | |
Collapse
|
10
|
Santos García D, Jesús S, Aguilar M, Planellas LL, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Catalán MJ, López Díaz L, Puente V, García Moreno JM, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Menéndez González M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, Fábregues‐Boixar O, González Ardura J, Prieto Jurczynska C, Martinez‐Martin P, Mir P, Adarmes Astrid D, Almeria M, Alonso Cánovas A, Alonso Frech F, Aneiros Díaz A, Arnáiz S, Arribas S, Ascunce Vidondo A, Bernardo Lambrich N, Bejr‐Kasem H, Blázquez Estrada M, Botí M, Cabello González C, Cámara Lorenzo A, Carrillo F, Casas E, Clavero P, Cortina Fernández A, Cots Foraster A, Crespo Cuevas A, de Deus Fonticoba T, Díez‐Fairen M, Erro E, Estelrich Peyret E, Fernández Guillán N, Gámez P, Gallego M, García Campos C, Gómez Garre MP, González Aloy J, González García B, González Palmás MJ, González Toledo GR, Golpe Díaz A, Grau Solá M, Guardia G, Horta‐Barba A, Infante J, Labandeira C, Labrador MA, Lacruz F, Lage Castro M, López Seoane B, Macías Y, Mata M, Martí Andres G, Martí MJ, McAfee D, Meitín MT, Méndez del Barrio C, Miranda Santiago J, Morales Casado MI, Moreno Diéguez A, Nogueira V, Novo Amado A, Novo Ponte S, Ordás C, Pagonabarraga J, Pareés I, Pascual‐Sedano B, Pastor P, Pérez Fuertes A, Pérez Noguera R, Prats MA, Pueyo Morlans M, Redondo Rafales N, Rodríguez Méndez L, Rodríguez Pérez AB, Roldán F, Ruíz De Arcos M, Sánchez‐Carpintero M, Sánchez Díez G, Sánchez Rodríguez A, Santacruz P, Segundo Rodríguez JC, Serarols A, Sierra Peña M, Suárez Castro E, Tartari JP, Vargas L, Vázquez Gómez R, Villanueva C, Vives B, Villar MD. COPPADIS
‐2015 (
CO
hort of Patients with PArkinson's
DI
sease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation. Eur J Neurol 2019; 26:1399-1407. [DOI: 10.1111/ene.14008] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2018] [Accepted: 05/23/2019] [Indexed: 01/03/2023]
Affiliation(s)
- D. Santos García
- CHUAC, Complejo Hospitalario Universitario de A Coruña A CoruñaSpain
| | - S. Jesús
- Hospital Universitario Virgen del Rocío SevillaSpain
| | - M. Aguilar
- Hospital Universitari Mutua de Terrassa Terrassa Barcelona Spain
| | | | | | - N. Caballol
- Consorci Sanitari Integral Hospital Moisés Broggi Sant Joan Despí Barcelona Spain
| | - I. Legarda
- Hospital Universitario Son Espases Palma de MallorcaSpain
| | | | - I. Cabo
- Complejo Hospitalario Universitario de Pontevedra (CHOP) PontevedraSpain
| | | | | | - M. A. Ávila Rivera
- Consorci Sanitari Integral Hospital General de L'Hospitalet, L'Hospitalet de Llobregat Barcelona Spain
| | - M. J. Catalán
- Hospital Universitario Clínico San Carlos Madrid Spain
| | - L. López Díaz
- Complejo Hospitalario Universitario de Orense (CHUO) Orense Spain
| | | | | | | | - B. Solano Vila
- Institut d'Assistència Sanitària (IAS) – Institut Català de la Salut Girona Spain
| | | | - L. Vela
- Fundación Hospital de Alcorcón MadridSpain
| | - S. Escalante
- Hospital de Tortosa Verge de la Cinta (HTVC) Tortosa Tarragona Spain
| | - E. Cubo
- Complejo Asistencial Universitario de Burgos Burgos Spain
| | - F. Carrillo Padilla
- Hospital Universitario de Canarias San Cristóbal de la LagunaSanta Cruz de Tenerife Spain
| | | | | | - M. G. Alonso Losada
- Hospital Álvaro Cunqueiro Complejo Hospitalario Universitario de Vigo (CHUVI) Vigo Spain
| | | | - I. Gastón
- Complejo Hospitalario de Navarra Pamplona Spain
| | | | | | - M. Seijo
- Complejo Hospitalario Universitario de Pontevedra (CHOP) PontevedraSpain
| | | | - C. Valero
- Hospital Arnau de Vilanova Valencia Spain
| | - M. Kurtis
- Hospital Ruber Internacional Madrid Spain
| | | | | | | | - P. Martinez‐Martin
- Centro Nacional de Epidemiología y CIBERNED Instituto de Salud Carlos III Madrid Spain
| | - P. Mir
- Hospital Universitario Virgen del Rocío SevillaSpain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Garcia-Arellano A, Martínez-González MA, Ramallal R, Salas-Salvadó J, Hébert JR, Corella D, Shivappa N, Forga L, Schröder H, Muñoz-Bravo C, Estruch R, Fiol M, Lapetra J, Serra-Majem L, Ros E, Rekondo J, Toledo E, Razquin C, Ruiz-Canela M, Alonso A, Barrio Lopez M, Basterra-Gortari F, Benito Corchon S, Bes-Rastrollo M, Beunza J, Carlos S, Cervantes S, de Irala J, de la Rosa P, de la Fuente C, Donat-Vargas C, Donazar M, Fernandez Montero A, Gea A, Goni-Ochandorena E, Guillen-Grima F, Lahortiga F, Llorca J, Lopez del Burgo C, Mari-Sanchıs A, Marti A, Mendonça R, Nuñez-Cordoba J, Pimenta A, Rico A, Ruiz Zambrana A, Sayon-Orea C, Toledo-Atucha J, Vazquez Ruiz Z, Zazpe Garcıa I, Sánchez- Tainta A, Buil-Cosiales P, Díez-Espino J, Sanjulian B, Martínez J, Marti A, Serrano-Martínez M, Basterra-Gortari F, Extremera-Urabayen J, Garcia-Pérez L, Arroyo-Azpa C, Barcena A, Oreja-Arrayago C, Lasanta-Sáez M, Cia-Lecumberri P, Elcarte-Lopez T, Artal-Moneva F, Esparza-López J, Figuerido-Garmendia E, Tabar-Sarrias J, Fernández- Urzainqui L, Ariz-Arnedo M, Cabeza-Beunza J, Pascual-Pascual P, Martínez-Mazo M, Arina-Vergara E, Macua-Martínez T, Pascual Pascual P, Garcés Ducar M, Martí Massó R, Villanueva Moreno R, Parra-Osés A, Serra-Mir M, Pérez-Heras A, Viñas C, Casas R, Medina-Remon A, Villanueva P, Baena J, García M, Oller M, Amat J, Duaso I, García Y, Iglesias C, Simón C, Quinzavos L, Parra L, Liroz M, Benavent J, Clos J, Pla I, Amorós M, Bonet M, Martín M, Sánchez M, Altirriba J, Manzano E, Altés A, Cofán M, Valls-Pedret C, Sala-Vila A, Doménech M, Bulló M, Basora-Gallisa J, González R, Molina C, Mena G, Martínez P, Ibarrola N, Sorlí J, García Roselló J, Martin F, Tort N, Isach A, Babio N, Salas-Huetos A, Becerra-Tomás N, Rosique- Esteban N, Hernandez P, Canudas S, Papandreou C, Ferreira C, Cabre M, Mestres G, Paris F, Llauradó M, Pedret R, Basells J, Vizcaino J, Segarra R, Giardina S, Guasch-Ferré M, Díaz-López A, Fernández-Ballart J, Balanza R, Tello S, Vila J, de la Torre R, Muñoz-Aguayo D, Elosua R, Marrugat J, Schröder H, Molina N, Maestre E, Rovira A, Castañer O, Farré M, Sorli J, Carrasco P, Ortega-Azorín C, Asensio E, Osma R, Barragán R, Francés F, Guillén M, González J, Sáiz C, Portolés O, Giménez F, Coltell O, Fernández-Carrión R, Guillem-Sáiz P, González-Monje I, Quiles L, Pascual V, Riera C, Pages M, Godoy D, Carratalá-Calvo A, Sánchez-Navarro S, Valero-Barceló C, Salaverria I, Hierro TD, Algorta J, Francisco S, Alonso A, San Vicente J, Casi A, Sanz E, Felipe I, Rekondo J, Loma-Osorio A, Fernandez-Crehuet J, Garcia-Rodriguez A, Wärnberg J, Benitez Pont R, Bianchi Alba M, Navajas R, Gómez-Huelgas R, Martínez-González J, Velasco García V, de Diego Salas J, Baca Osorio A, Gil Zarzosa J, Sánchez Luque J, Vargas López E, Romaguera D, García-Valdueza M, Proenza A, Prieto R, Frontera G, Munuera S, Vivó M, Bestard F, Munar J, Coll L, Fiol F, Ginard M, Jover A, García J, Santos-Lozano J, Ortega-Calvo M, Leal M, Martínez E, Mellado L, Miró-Moriano L, Domínguez-Espinaco C, Vaquero- Diaz S, Iglesias P, Román P, Corchado Y, Lozano-Rodríguez J, Lamuela-Raventós R, López- Sabater M, Castellote-Bargalló A, Quifer-Rada P, Tresserra-Rimbau A, Alvarez-Pérez J, Díez Benítez E, Bautista Castaño I, Maldonado Díaz I, Sanchez-Villegas A, Férnandez- Rodríguez M, Sarmiendo de la Fe F, Simón García C, Falcón Sanabria I, Macías Gutiérrez B, Santana Santana A, de la Cruz E, Galera A, Pintó-Salas X, Trias F, Sarasa I, Rodríguez M, Corbella X, Corbella E, Goday A, Muñoz M, Cabezas C, Vinyoles E, Rovira M, Garcia L, Baby P, Ramos A, Mengual L, Roura P, Yuste M, Guarner A, Rovira A, Santamaria M, Mata M, de Juan C, Brau A, Fernandez M, Gutierrez E, Murillo C, Garcia J, Tafalla M, Bobe I, Díaz A, Araque M, Solis E, Cervello T, Montull I, Tur J, Portillo M, Sáez G. Dietary inflammatory index and all-cause mortality in large cohorts: The SUN and PREDIMED studies. Clin Nutr 2019; 38:1221-1231. [PMID: 30651193 DOI: 10.1016/j.clnu.2018.05.003] [Citation(s) in RCA: 72] [Impact Index Per Article: 14.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2017] [Revised: 04/24/2018] [Accepted: 05/02/2018] [Indexed: 12/22/2022]
|
12
|
Crous P, Wingfield M, Burgess T, Hardy G, Barber P, Alvarado P, Barnes C, Buchanan P, Heykoop M, Moreno G, Thangavel R, van der Spuy S, Barili A, Barrett S, Cacciola S, Cano-Lira J, Crane C, Decock C, Gibertoni T, Guarro J, Guevara-Suarez M, Hubka V, Kolařík M, Lira C, Ordoñez M, Padamsee M, Ryvarden L, Soares A, Stchigel A, Sutton D, Vizzini A, Weir B, Acharya K, Aloi F, Baseia I, Blanchette R, Bordallo J, Bratek Z, Butler T, Cano-Canals J, Carlavilla J, Chander J, Cheewangkoon R, Cruz R, da Silva M, Dutta A, Ercole E, Escobio V, Esteve-Raventós F, Flores J, Gené J, Góis J, Haines L, Held B, Jung MH, Hosaka K, Jung T, Jurjević Ž, Kautman V, Kautmanova I, Kiyashko A, Kozanek M, Kubátová A, Lafourcade M, La Spada F, Latha K, Madrid H, Malysheva E, Manimohan P, Manjón J, Martín M, Mata M, Merényi Z, Morte A, Nagy I, Normand AC, Paloi S, Pattison N, Pawłowska J, Pereira O, Petterson M, Picillo B, Raj K, Roberts A, Rodríguez A, Rodríguez-Campo F, Romański M, Ruszkiewicz-Michalska M, Scanu B, Schena L, Semelbauer M, Sharma R, Shouche Y, Silva V, Staniaszek-Kik M, Stielow J, Tapia C, Taylor P, Toome-Heller M, Vabeikhokhei J, van Diepeningen A, Van Hoa N, M. VT, Wiederhold N, Wrzosek M, Zothanzama J, Groenewald J. Fungal Planet description sheets: 558-624. Persoonia 2017; 38:240-384. [PMID: 29151634 PMCID: PMC5645186 DOI: 10.3767/003158517x698941] [Citation(s) in RCA: 90] [Impact Index Per Article: 12.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/01/2017] [Accepted: 05/01/2017] [Indexed: 01/20/2023]
Abstract
Novel species of fungi described in this study include those from various countries as follows: Australia: Banksiophoma australiensis (incl. Banksiophoma gen. nov.) on Banksia coccinea, Davidiellomycesaustraliensis (incl. Davidiellomyces gen. nov.) on Cyperaceae, Didymocyrtis banksiae on Banksia sessilis var. cygnorum, Disculoides calophyllae on Corymbia calophylla, Harknessia banksiae on Banksia sessilis, Harknessia banksiae-repens on Banksia repens, Harknessia banksiigena on Banksia sessilis var. cygnorum, Harknessia communis on Podocarpus sp., Harknessia platyphyllae on Eucalyptus platyphylla, Myrtacremonium eucalypti (incl. Myrtacremonium gen. nov.) on Eucalyptus globulus, Myrtapenidiella balenae on Eucalyptus sp., Myrtapenidiella eucalyptigena on Eucalyptus sp., Myrtapenidiella pleurocarpae on Eucalyptuspleurocarpa, Paraconiothyrium hakeae on Hakea sp., Paraphaeosphaeria xanthorrhoeae on Xanthorrhoea sp., Parateratosphaeria stirlingiae on Stirlingia sp., Perthomyces podocarpi (incl. Perthomyces gen. nov.) on Podocarpus sp., Readeriella ellipsoidea on Eucalyptus sp., Rosellinia australiensis on Banksia grandis, Tiarosporella corymbiae on Corymbia calophylla, Verrucoconiothyriumeucalyptigenum on Eucalyptus sp., Zasmidium commune on Xanthorrhoea sp., and Zasmidium podocarpi on Podocarpus sp. Brazil: Cyathus aurantogriseocarpus on decaying wood, Perenniporia brasiliensis on decayed wood, Perenniporia paraguyanensis on decayed wood, and Pseudocercospora leandrae-fragilis on Leandrafragilis.Chile: Phialocephala cladophialophoroides on human toe nail. Costa Rica: Psathyrella striatoannulata from soil. Czech Republic: Myotisia cremea (incl. Myotisia gen. nov.) on bat droppings. Ecuador: Humidicutis dictiocephala from soil, Hygrocybe macrosiparia from soil, Hygrocybe sangayensis from soil, and Polycephalomyces onorei on stem of Etlingera sp. France: Westerdykella centenaria from soil. Hungary: Tuber magentipunctatum from soil. India: Ganoderma mizoramense on decaying wood, Hodophilus indicus from soil, Keratinophyton turgidum in soil, and Russula arunii on Pterigota alata.Italy: Rhodocybe matesina from soil. Malaysia: Apoharknessia eucalyptorum, Harknessia malayensis, Harknessia pellitae, and Peyronellaea eucalypti on Eucalyptus pellita, Lectera capsici on Capsicum annuum, and Wallrothiella gmelinae on Gmelina arborea.Morocco: Neocordana musigena on Musa sp. New Zealand: Candida rongomai-pounamu on agaric mushroom surface, Candida vespimorsuum on cup fungus surface, Cylindrocladiella vitis on Vitis vinifera, Foliocryphia eucalyptorum on Eucalyptus sp., Ramularia vacciniicola on Vaccinium sp., and Rhodotorula ngohengohe on bird feather surface. Poland: Tolypocladium fumosum on a caterpillar case of unidentified Lepidoptera.Russia: Pholiotina longistipitata among moss. Spain: Coprinopsis pseudomarcescibilis from soil, Eremiomyces innocentii from soil, Gyroporus pseudocyanescens in humus, Inocybe parvicystis in humus, and Penicillium parvofructum from soil. Unknown origin: Paraphoma rhaphiolepidis on Rhaphiolepsis indica.USA: Acidiella americana from wall of a cooling tower, Neodactylaria obpyriformis (incl. Neodactylaria gen. nov.) from human bronchoalveolar lavage, and Saksenaea loutrophoriformis from human eye. Vietnam: Phytophthora mekongensis from Citrus grandis, and Phytophthora prodigiosa from Citrus grandis. Morphological and culture characteristics along with DNA barcodes are provided.
Collapse
Affiliation(s)
- P.W. Crous
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
| | - M.J. Wingfield
- Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria 0002, South Africa
| | - T.I. Burgess
- Centre for Phytophthora Science and Management, Murdoch University, 90 South Street, Murdoch, WA 6150, Australia
| | - G.E.St.J. Hardy
- Centre for Phytophthora Science and Management, Murdoch University, 90 South Street, Murdoch, WA 6150, Australia
| | - P.A. Barber
- ArborCarbon, P.O. Box 1065, Willagee Central, WA 6156, Australia; 1 City Farm Place, East Perth, Western Australia, 6004 Australia
| | - P. Alvarado
- ALVALAB, C/ La Rochela nº 47, E-39012 Santander, Spain
| | - C.W. Barnes
- Instituto Nacional de Investigaciones Agropecuarias, Estación Experimental Santa Catalina, Panamericana Sur Km1, Sector Cutuglahua, Pichincha, Ecuador
| | - P.K. Buchanan
- Landcare Research, Private Bag 92170, Auckland 1142, New Zealand
| | - M. Heykoop
- Departamento de Ciencias de la Vida (Área de Botánica), Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain
| | - G. Moreno
- Departamento de Ciencias de la Vida (Área de Botánica), Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain
| | - R. Thangavel
- Plant Health and Environment Laboratory, Ministry for Primary Industries, P.O. Box 2095, Auckland 1140, New Zealand
| | - S. van der Spuy
- Macleans College, 2 Macleans Rd, Bucklands Beach, Auckland 2014, New Zealand
| | - A. Barili
- Escuela de Ciencias Biológicas, Pontificia Universidad Católica del Ecuador, Av. 12 de octubre 1076 y Roca, Quito, Ecuador
| | - S. Barrett
- Department of Parks and Wildlife Albany District, 120 Albany Highway, Albany, WA 6330, Australia
| | - S.O. Cacciola
- Department of Agriculture, Food and Environment (Di3A), University of Catania, Via Santa Sofia 100, 95123 Catania, Italy
| | - J.F. Cano-Lira
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili (URV), Sant Llorenç 21, 43201 Reus, Tarragona, Spain
| | - C. Crane
- Department of Parks and Wildlife, Vegetation Health Service, Locked Bag 104, Bentley Delivery Centre, Bentley, WA 6983, Australia
| | - C. Decock
- Mycothèque de l’Université catholique de Louvain (MUCL, BCCMTM), Earth and Life Institute – Microbiology (ELIM), Université catholique de Louvain, Croix du Sud 2 bte L7.05.06, B-1348, Louvain-la-Neuve, Belgium
| | - T.B. Gibertoni
- Departamento de Micologia Prof. Chaves Batista, Universidade Federal de Pernambuco, Recife, Brazil
| | - J. Guarro
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili (URV), Sant Llorenç 21, 43201 Reus, Tarragona, Spain
| | - M. Guevara-Suarez
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili (URV), Sant Llorenç 21, 43201 Reus, Tarragona, Spain
| | - V. Hubka
- Department of Botany, Faculty of Science, Charles University, Benátská 2, 128 01 Prague 2, Czech Republic
| | - M. Kolařík
- Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology of the CAS, v.v.i, Vídeňská 1083, 142 20 Prague 4, Czech Republic
| | - C.R.S. Lira
- Departamento de Micologia Prof. Chaves Batista, Universidade Federal de Pernambuco, Recife, Brazil
| | - M.E. Ordoñez
- Escuela de Ciencias Biológicas, Pontificia Universidad Católica del Ecuador, Av. 12 de octubre 1076 y Roca, Quito, Ecuador
| | - M. Padamsee
- Landcare Research, Private Bag 92170, Auckland 1142, New Zealand
| | - L. Ryvarden
- University of Oslo, Institute of Biological Sciences, P.O. Box 1066, Blindern, N-0316, Oslo, Norway
| | - A.M. Soares
- Departamento de Micologia Prof. Chaves Batista, Universidade Federal de Pernambuco, Recife, Brazil
| | - A.M. Stchigel
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili (URV), Sant Llorenç 21, 43201 Reus, Tarragona, Spain
| | - D.A. Sutton
- Fungus Testing Laboratory, Department of Pathology, University of Texas Health Science Center, San Antonio, Texas, USA
| | - A. Vizzini
- Department of Life Sciences and Systems Biology, University of Torino, Viale P.A. Mattioli 25, I-10125 Torino, Italy; Institute for Sustainable Plant Protection (IPSP)-CNR, Viale P.A. Mattioli 25, I-10125 Torino, Italy
| | - B.S. Weir
- Landcare Research, Private Bag 92170, Auckland 1142, New Zealand
| | - K. Acharya
- Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany, University of Calcutta, 35, Ballygunge Circular Road, Kolkata-700019, West Bengal, India
| | - F. Aloi
- Department of Agriculture, Food and Environment (Di3A), University of Catania, Via Santa Sofia 100, 95123 Catania, Italy
| | - I.G. Baseia
- Departamento de Botânica e Zoologia, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
| | - R.A. Blanchette
- University of Minnesota, 495 Borlaug Hall, 1991 Upper Buford Circle, St. Paul, MN 55108, USA
| | - J.J. Bordallo
- Departamento de Biología Vegetal (Botánica), Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain
| | - Z. Bratek
- Department of Plant Physiology and Molecular Plant Biology, Eötvös Loránd University, Pázmány Péter lane 1/C, Budapest H-1117, Hungary
| | - T. Butler
- Te Kura Kaupapa Māori o Kaikohe, 20 Hongi Street, Kaikohe 0405, New Zealand
| | - J. Cano-Canals
- Te Kura Kaupapa Māori o Kaikohe, 20 Hongi Street, Kaikohe 0405, New Zealand
| | - J.R. Carlavilla
- Departamento de Ciencias de la Vida (Área de Botánica), Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain
| | - J. Chander
- Department of Microbiology, Government Medical College Hospital, 32B, Sector 32, Chandigarh, 160030, India
| | - R. Cheewangkoon
- Department of Entomology and Plant Pathology, Faculty of Agriculture, Chiang Mai University, Chiang Mai 50200, Thailand
| | - R.H.S.F. Cruz
- Programa de Pós-graduação em Sistemática e Evolução, Dept. Botânica e Zoologia, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Natal, 59078-970, Brazil
| | - M. da Silva
- Universidade Federal de Viçosa, Minas Gerais, Brazil
| | - A.K. Dutta
- Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany, University of Calcutta, 35, Ballygunge Circular Road, Kolkata-700019, West Bengal, India
| | - E. Ercole
- Department of Life Sciences and Systems Biology, University of Turin, I-10125 Turin, Italy
| | - V. Escobio
- Sociedad Micológica de Gran Canaria, Apartado 609, 35080 Las Palmas de Gran Canaria, Spain
| | - F. Esteve-Raventós
- Departamento de Ciencias de la Vida (Área de Botánica), Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain
| | - J.A. Flores
- Escuela de Ciencias Biológicas, Pontificia Universidad Católica del Ecuador, Av. 12 de octubre 1076 y Roca, Quito, Ecuador
| | - J. Gené
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili (URV), Sant Llorenç 21, 43201 Reus, Tarragona, Spain
| | - J.S. Góis
- Departamento de Botânica e Zoologia, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
| | - L. Haines
- Te Kura Kaupapa Māori o Kaikohe, 20 Hongi Street, Kaikohe 0405, New Zealand
| | - B.W. Held
- University of Minnesota, 495 Borlaug Hall, 1991 Upper Buford Circle, St. Paul, MN 55108, USA
| | - M. Horta Jung
- Phytophthora Research Center, Mendel University, Zemedelska 1, 613 00 Brno, Czech Republic; Phytophthora Research and Consultancy, Am Rain 9, 83131 Nußdorf, Germany
| | - K. Hosaka
- Department of Botany, National Museum of Nature and Science-TNS, 4-1-1 Amakubo, Tsukuba, Ibaraki, 305-0005, Japan
| | - T. Jung
- Phytophthora Research Center, Mendel University, Zemedelska 1, 613 00 Brno, Czech Republic; Phytophthora Research and Consultancy, Am Rain 9, 83131 Nußdorf, Germany
| | - Ž. Jurjević
- EMSL Analytical, Inc., 200 Route 130 North, Cinnaminson, NJ 08077, USA
| | | | - I. Kautmanova
- Slovak National Museum-Natural History Museum, Vajanskeho nab. 2, P.O. Box 13, 81006 Bratislava, Slovakia
| | - A.A. Kiyashko
- Komarov Botanical Institute of the Russian Academy of Sciences, Saint Petersburg, Russia
| | - M. Kozanek
- Scientica, Ltd., Hybesova 33, 83106 Bratislava, Slovakia
| | - A. Kubátová
- Department of Botany, Faculty of Science, Charles University, Benátská 2, 128 01 Prague 2, Czech Republic
| | - M. Lafourcade
- Laboratorio Clínico, Clínica Santa María, Santiago, Chile
| | - F. La Spada
- Department of Agriculture, Food and Environment (Di3A), University of Catania, Via Santa Sofia 100, 95123 Catania, Italy
| | - K.P.D. Latha
- Department of Botany, University of Calicut, Kerala, 673 635, India
| | - H. Madrid
- Centro de Genómica y Bioinformática, Facultad de Ciencias, Universidad Mayor de Chile, Camino La Pirámide 5750, Huechuraba, Santiago, Chile
| | - E.F. Malysheva
- Komarov Botanical Institute of the Russian Academy of Sciences, Saint Petersburg, Russia
| | - P. Manimohan
- Department of Botany, University of Calicut, Kerala, 673 635, India
| | - J.L. Manjón
- Departamento de Ciencias de la Vida (Área de Botánica), Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain
| | - M.P. Martín
- Departamento de Micología, Real Jardín Botánico-CSIC, Plaza de Murillo 2, 28014 Madrid, Spain
| | - M. Mata
- Escuela de Biología, Universidad de Costa Rica, Sede Central, San Pedro de Montes Oca. San José, Costa Rica
| | - Z. Merényi
- Department of Plant Physiology and Molecular Plant Biology, Eötvös Loránd University, Pázmány Péter lane 1/C, Budapest H-1117, Hungary
| | - A. Morte
- Departamento de Biología Vegetal (Botánica), Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain
| | - I. Nagy
- Department of Plant Physiology and Molecular Plant Biology, Eötvös Loránd University, Pázmány Péter lane 1/C, Budapest H-1117, Hungary
| | - A.-C. Normand
- Département de Parasitologie/Mycologie La Timone, Marseille, France
| | - S. Paloi
- Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany, University of Calcutta, 35, Ballygunge Circular Road, Kolkata-700019, West Bengal, India
| | - N. Pattison
- Rongomai School, 20 Rongomai Rd, Otara, Auckland 2023, New Zealand
| | - J. Pawłowska
- Department of Molecular Phylogenetics and Evolution, University of Warsaw, Żwirki and Wigury 101, PL-02-089 Warsaw, Poland
| | - O.L. Pereira
- Universidade Federal de Viçosa, Minas Gerais, Brazil
| | - M.E. Petterson
- Landcare Research, Private Bag 92170, Auckland 1142, New Zealand
| | - B. Picillo
- Via Roma 139, I-81017 Sant’ Angelo d’ Alife (CE), Italy
| | - K.N.A. Raj
- Department of Botany, University of Calicut, Kerala, 673 635, India
| | - A. Roberts
- Karamu High School, Windsor Ave, Parkvale, Hastings 4122, New Zealand
| | - A. Rodríguez
- Departamento de Biología Vegetal (Botánica), Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain
| | | | - M. Romański
- Wigry National Park, Krzywe 82, PL-16-402 Suwałki, Poland
| | | | - B. Scanu
- Dipartimento di Agraria, University of Sassari, Viale Italia 39, 07100 Sassari, Italy
| | - L. Schena
- Dipartimento di Agraria, Mediterranean University of Reggio Calabria, Feo di Vito, 89122 Reggio Calabria, Italy
| | - M. Semelbauer
- Institute of Zoology, Slovak Academy of Sciences, Dubravska cesta 9, 84506 Bratislava, Slovakia
| | - R. Sharma
- National Centre for Microbial Resource, National Centre for Cell Science, NCCS Complex SP Pune University Campus, Ganeshkhind, Pune 411007, India
| | - Y.S. Shouche
- National Centre for Microbial Resource, National Centre for Cell Science, NCCS Complex SP Pune University Campus, Ganeshkhind, Pune 411007, India
| | - V. Silva
- Escuela de Tecnología Médica, Facultad de Ciencias, Universidad Mayor de Chile, Santiago, Chile
| | - M. Staniaszek-Kik
- Department of Geobotany and Plant Ecology, University of Łódź, Banacha 12/16, PL-90-237 Łódź, Poland
| | - J.B. Stielow
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
| | - C. Tapia
- Laboratorio de Micología Médica, Programa de Microbiología y Micología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile
| | - P.W.J. Taylor
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Australia
| | - M. Toome-Heller
- Plant Health and Environment Laboratory, Ministry for Primary Industries, P.O. Box 2095, Auckland 1140, New Zealand
| | | | - A.D. van Diepeningen
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
| | - N. Van Hoa
- Southern Horticultural Research Institute, My Tho, Tien Giang, Vietnam
| | - Van Tri M.
- Southern Horticultural Research Institute, My Tho, Tien Giang, Vietnam
| | - N.P. Wiederhold
- Fungus Testing Laboratory, Department of Pathology, University of Texas Health Science Center, San Antonio, Texas, USA
| | - M. Wrzosek
- Department of Molecular Phylogenetics and Evolution, University of Warsaw, Żwirki and Wigury 101, PL-02-089 Warsaw, Poland
| | | | - J.Z. Groenewald
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
| |
Collapse
|
13
|
Affiliation(s)
- A.M. Stchigel
- Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/ Sant Llorenç 21, 43201 Reus, Tarragona, Spain
| | - L. Umaña
- Instituto Nacional de Biodiversidad (INBio), Apartado Postal 22-3100, Santo Domingo, Heredia, Costa Rica
| | - J. Guarro
- Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/ Sant Llorenç 21, 43201 Reus, Tarragona, Spain
| | - M. Mata
- Instituto Nacional de Biodiversidad (INBio), Apartado Postal 22-3100, Santo Domingo, Heredia, Costa Rica
| |
Collapse
|
14
|
Tovar B, Mata M, García H. Note. Physiological changes in bananas subjected to automodified atmosphere / Nota. Cambios fisiológicos de plátanos envasados en atmósfera modificada. FOOD SCI TECHNOL INT 2016. [DOI: 10.1177/108201320000600110] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Physiological changes during the ripening of whole and peeled bananas stored in chambers with automodified atmospheres were evaluated. Calcium carbide was applied to preclimacteric bananas for ripening initiation. Three different lots were placed into glass containers, which were maintained at 20 ± 0.5 °C. The treatments evaluated were: peeled bananas inside the glass container, whole (unpeeled) bananas inside the glass containers, and control, unpeeled bananas outside the chambers. Peeling of firm green fruits did not induce spoilage nor interfere with the normal ripening of the bananas when they were kept inside the automodified atmosphere. Under this storage, peeled ba nanas showed better qualities than whole bananas. The ripeness of peeled bananas in automodified atmospheres was similar to that of control fruits.
Collapse
Affiliation(s)
- B. Tovar
- Instituto Tecnológico de Veracruz, Apdo. Postal 1420, Veracruz, Veracruz, México
| | - M. Mata
- Instituto Tecnológico de Tepic, Apdo. Postal 634, Tepic, Nayarit, México
| | - H.S. García
- Instituto Tecnológico de Veracruz, Apdo. Postal 1420, Veracruz, Veracruz, México
| |
Collapse
|
15
|
Vela L, Martínez Castrillo J, García Ruiz P, Gasca-Salas C, Macías Macías Y, Pérez Fernández E, Ybot I, Lopez Valdés E, Kurtis M, Posada Rodriguez I, Mata M, Ruiz Huete C, Eimil M, Borrue C, del Val J, López-Manzanares L, Rojo Sebastian A, Marasescu R. The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study. J Neurol Sci 2016; 368:150-4. [DOI: 10.1016/j.jns.2016.07.003] [Citation(s) in RCA: 100] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2015] [Revised: 05/20/2016] [Accepted: 07/01/2016] [Indexed: 11/16/2022]
|
16
|
Peña E, Mata M, López-Manzanares L, Kurtis M, Eimil M, Martínez-Castrillo JC, Navas I, Posada IJ, Prieto C, Ruíz-Huete C, Vela L, Venegas B. Antidepressants in Parkinson's disease. Recommendations by the movement disorder study group of the Neurological Association of Madrid. Neurologia 2016; 33:S0213-4853(16)00055-4. [PMID: 27004670 DOI: 10.1016/j.nrl.2016.02.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2015] [Revised: 01/29/2016] [Accepted: 02/01/2016] [Indexed: 01/07/2023] Open
Abstract
INTRODUCTION Although antidepressants are widely used in Parkinson's disease (PD), few well-designed studies to support their efficacy have been conducted. DEVELOPMENT These clinical guidelines are based on a review of the literature and the results of an AMN movement disorder study group survey. CONCLUSIONS Evidence suggests that nortriptyline, venlafaxine, paroxetine, and citalopram may be useful in treating depression in PD, although studies on paroxetine and citalopram yield conflicting results. In clinical practice, however, selective serotonin reuptake inhibitors are usually considered the treatment of choice. Duloxetine may be an alternative to venlafaxine, although the evidence for this is less, and venlafaxine plus mirtazapine may be useful in drug-resistant cases. Furthermore, citalopram may be indicated for the treatment of anxiety, atomoxetine for hypersomnia, trazodone and mirtazapine for insomnia and psychosis, and bupropion for apathy. In general, antidepressants are well tolerated in PD. However, clinicians should consider the anticholinergic effect of tricyclic antidepressants, the impact of serotonin-norepinephrine reuptake inhibitors on blood pressure, the extrapyramidal effects of antidepressants, and any potential interactions between monoamine oxidase B inhibitors and other antidepressants.
Collapse
Affiliation(s)
- E Peña
- Servicio de Neurología, Hospital Sanitas La Moraleja, Madrid, España.
| | - M Mata
- Servicio de Neurología, Hospital Infanta Sofía, Madrid, España
| | | | - M Kurtis
- Servicio de Neurología, Hospital Ruber Internacional, Madrid, España
| | - M Eimil
- Servicio de Neurología, Hospital de Torrejón, Madrid, España
| | | | - I Navas
- Servicio de Neurología, Hospital Fundación Jiménez Díaz, Madrid, España
| | - I J Posada
- Servicio de Neurología, Hospital 12 de Octubre, Madrid, España
| | - C Prieto
- Servicio de Neurología, Hospitales Rey Juan Carlos, Infanta Elena y Villalba, Madrid, España
| | - C Ruíz-Huete
- Servicio de Neurología, Clínica del Rosario, Madrid, España
| | - L Vela
- Servicio de Neurología, Hospital Fundación Alcorcón, Madrid, España
| | - B Venegas
- Servicio de Neurología, Hospitales Rey Juan Carlos, Infanta Elena y Villalba, Madrid, España
| |
Collapse
|
17
|
Wu Z, Wang S, Wu I, Mata M, Fink DJ. Activation of TLR-4 to produce tumour necrosis factor-α in neuropathic pain caused by paclitaxel. Eur J Pain 2014; 19:889-98. [PMID: 25388329 DOI: 10.1002/ejp.613] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/22/2014] [Indexed: 12/12/2022]
Abstract
BACKGROUND Neuropathic pain is a common complication of treatment with the anti-neoplastic drug paclitaxel. Animal studies suggest neuroinflammation and transient receptor potential channels TRPA1 and TRPV4 are involved in the pathogenesis of pain in this condition. However, how neuroinflammation and TRPA1 and TRPV4 are linked to cause pain in paclitaxel-treated animals is not known. METHODS Paclitaxel-induced pain was modelled by IP injection of paclitaxel (16 mg/kg) once a week for 5 weeks. The role of toll-like receptor 4 (TLR-4) in tumour necrosis factor-α (TNF-α) production and the effect of TNF-α on the expression of TRPA1 and TRPV4 were evaluated in vitro and in vivo. TNF-α signalling in dorsal root ganglion (DRG) was blocked by expressing soluble TNF receptor I (TNFsR) from a herpes simplex virus (HSV)-based vector (vTNFsR). RESULTS Paclitaxel treatment increased the expression and release of TNF-α in satellite glial cells and increased the expression of TRPA1 and TRPV4 in DRG neurons in animals. In vitro, paclitaxel enhanced the expression and release of TNF-α in enriched primary satellite glial cells, an effect that was blocked by an inhibitor of TLR-4. Direct application of TNF-α to primary DRG neurons in culture up-regulated the expression of TRPA1 and TRPV4. In vivo, vector-mediated TNFsR release from DRG neurons reduced paclitaxel-induced up-regulation of TRPA1 and TRPV4 expression and prevented paclitaxel-induced pain. CONCLUSION These results suggest that paclitaxel activation of TLR-4 to cause release of TNF-α from satellite glial cells increases the expression of TRPA1 and TRPV4 in DRG neurons to cause neuropathic pain.
Collapse
Affiliation(s)
- Z Wu
- Department of Neurology, University of Michigan, USA.,VA Ann Arbor Healthcare System, USA
| | - S Wang
- Department of Neurology, University of Michigan, USA.,VA Ann Arbor Healthcare System, USA
| | - I Wu
- Department of Neurology, University of Michigan, USA.,VA Ann Arbor Healthcare System, USA
| | - M Mata
- Department of Neurology, University of Michigan, USA.,VA Ann Arbor Healthcare System, USA
| | - D J Fink
- Department of Neurology, University of Michigan, USA.,VA Ann Arbor Healthcare System, USA
| |
Collapse
|
18
|
Aguerri M, Calzada D, Montaner D, Mata M, Florido F, Quiralte J, Dopazo J, Lahoz C, Cardaba B. Differential gene-expression analysis defines a molecular pattern related to olive pollen allergy. J BIOL REG HOMEOS AG 2013; 27:337-350. [PMID: 23830385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Analysis of gene-expression profiles by microarrays is useful for characterization of candidate genes, key regulatory networks, and to define phenotypes or molecular signatures which improve the diagnosis and/or classification of the allergic processes. We have used this approach in the study of olive pollen response in order to find differential molecular markers among responders and non-responders to this allergenic source. Five clinical groups, non-allergic, asymptomatic, allergic but not to olive pollen, untreated-olive-pollen allergic patients and olive-pollen allergic patients (under specific-immunotherapy), were assessed during and outside pollen seasons. Whole-genome gene expression analysis was performed in RNAs extracted from PBMCs. After assessment of data quality and principal components analysis (PCA), differential gene-expression, by multiple testing and, functional analyses by KEGG, for pathways and Gene-Ontology for biological processes were performed. Relevance was defined by fold change and corrected P values (less than 0.05). The most differential genes were validated by qRT-PCR in a larger set of individuals. Interestingly, gene-expression profiling obtained by PCA clearly showed five clusters of samples that correlated with the five clinical groups. Furthermore, differential gene expression and functional analyses revealed differential genes and pathways in the five clinical groups. The 93 most significant genes found were validated, and one set of 35 genes was able to discriminate profiles of olive pollen response. Our results, in addition to providing new information on allergic response, define a possible molecular signature for olive pollen allergy which could be useful for the diagnosis and treatment of this and other sensitizations.
Collapse
Affiliation(s)
- M Aguerri
- Immunology Department, IIS-Fundacion Jimenez Diaz, Madrid, Spain
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Espinosa I, Ortiz R, Tovar B, Mata M, Montalvo E. Physiological and Physicochemical Behavior of Soursop Fruits Refrigerated with 1-Methylcyclopropene. J FOOD QUALITY 2012. [DOI: 10.1111/jfq.12011] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Affiliation(s)
- I. Espinosa
- Laboratorio Integral de Investigación en Alimentos; Instituto Tecnológico de Tepic; Av. Tecnológico 2595 Tepic Nayarit CP 63175 Mexico
| | - R.I. Ortiz
- Laboratorio Integral de Investigación en Alimentos; Instituto Tecnológico de Tepic; Av. Tecnológico 2595 Tepic Nayarit CP 63175 Mexico
| | - B. Tovar
- Laboratorio Integral de Investigación en Alimentos; Instituto Tecnológico de Tepic; Av. Tecnológico 2595 Tepic Nayarit CP 63175 Mexico
| | - M. Mata
- Laboratorio Integral de Investigación en Alimentos; Instituto Tecnológico de Tepic; Av. Tecnológico 2595 Tepic Nayarit CP 63175 Mexico
| | - E. Montalvo
- Laboratorio Integral de Investigación en Alimentos; Instituto Tecnológico de Tepic; Av. Tecnológico 2595 Tepic Nayarit CP 63175 Mexico
| |
Collapse
|
20
|
Abstract
We previously reported regulated expression of erythropoietin (EPO) over 4 weeks in the peripheral nerve in vivo, using a herpes simplex virus (HSV)-based vector containing a Tet-on regulatable gene expression cassette. To create a vector that would be appropriate for the treatment of chronic neuropathy, we constructed a HSV vector with expression of EPO under the control of the Tet-on system in which the HSV latency-associated promoter 2 element was used to drive the expression of the Tet-on transactivator. EPO expression from the vector was tightly controlled by administration of doxycycline (DOX) in vitro. One month after inoculation of the vector to transduce dorsal root ganglion (DRG) in vivo, administration of DOX-containing chow-induced expression of EPO. Mice with streptozotocin-induced diabetes, inoculated with the vector, were protected against the development of neuropathy by continuous administration of DOX-containing chow over the course of 3 months. Identical results were achieved when DOX was administered every other week over 3 months of diabetes, but administration of DOX, 1 week out of 3, provided only partial protection against the development of neuropathy. Taken together, these results suggest such a vector is well suited for clinical trial for the treatment of chronic or subacutely developing neuropathy.
Collapse
Affiliation(s)
- Z Wu
- Department of Neurology, University of Michigan and VA Ann Arbor Healthcare System, Ann Arbor, MI 48109, USA
| | | | | |
Collapse
|
21
|
Wang S, Wu Z, Chiang P, Fink DJ, Mata M. Vector-mediated expression of erythropoietin improves functional outcome after cervical spinal cord contusion injury. Gene Ther 2011; 19:907-14. [PMID: 22052241 DOI: 10.1038/gt.2011.166] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
We evaluated the therapeutic effect of erythropoietin (EPO) delivered by direct injection of a nonreplicating herpes simplex virus (HSV)-based vector coding for EPO (vEPO) in a model of cervical hemicord contusion at C7. At 1 h after spinal cord injury (SCI), either vEPO or control vector carrying a reporter gene (vC) was injected into the cord above and below the lesion. Animals injected with vEPO showed a statistically significant improvement in the ipsilateral forelimb function, as measured by open-field evaluation of motor performance, forelimb reaching in the cylinder test and misplacement in grid walk. This correlated with preservation of gray matter in the area of the lesion. There was also mild but significant improvement of hindlimb motor function measured by Basso-Beattie-Bresnahan score and computerized gait analysis in vEPO compared with control vector-injected animals. Microtubule-associated protein tau, phosphorylated and nonphosphorylated neurofilament protein and the synaptic proteins synaptophysin and PSD-95 were all significantly increased in the spinal cord of vEPO-treated animals compared with control vector-injected animals. These data suggest that gene transfer of EPO after cervical SCI by minimizing the injury size and enhancing tissue sparing preserves large-caliber axons and promotes synaptogenesis.
Collapse
Affiliation(s)
- S Wang
- Department of Neurology, University of Michigan and VA Ann Arbor Healthcare System, Ann Arbor, MI 48109, USA
| | | | | | | | | |
Collapse
|
22
|
Abstract
Opiate/narcotic analgesics are the most effective treatments for chronic severe pain, but their clinical utility is often hampered by the development of analgesic tolerance. Recent evidence suggests chronic morphine may activate glial cells to release proinflammatory cytokines. In this study, we used herpes simplex virus (HSV) vectors-based gene transfer to dorsal root ganglion to produce a local release of p55 TNF soluble receptor in the spinal cord in rats with morphine tolerance. Subcutaneous inoculation of HSV vectors expressing p55 TNF soluble receptor into the plantar surface of the hindpaws, enhanced the antinociceptive effect of acute morphine in rats. Subcutaneous inoculation of those vectors into hindpaws also delayed the development of chronic morphine tolerance in rats. TNF soluble receptor expressed by HSV vector reduced gene transcription of mRNA of spinal TNFα and IL-1β induced by repeated morphine. Furthermore, we found that TNF soluble receptor mediated by HSV, reversed the upregulation of TNFα, IL-1β and phosphorylation of p38 mitogen-activated protein kinase (MAPK) induced by repeated morphine. These results support the concept that proinflammatory cytokines may play an important role in the pathogenesis induced by morphine. This study provides a novel approach to treating morphine tolerance.
Collapse
Affiliation(s)
- J Sun
- Department of Neurology, University of Michigan, Ann Arbor, MI, USA
| | | | | | | | | |
Collapse
|
23
|
Medoro G, Gross S, Manaresi N, Sergio M, Fontana F, Gianni S, Calanca A, Peruzzi E, Banzi M, Signorini G, Rao C, Patel J, Karkera J, Giorgini G, Mata M, Connelly MC. Use of the DEPArray platform to detect, isolate, and molecularly characterize pure tumor cells from peripheral blood samples enriched using the CellSearch system. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.10616] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
24
|
Cárdaba B, Aguerri M, Florido F, Montaner D, Mata M, López-Cacho J, Gallardo S, Dopazo J, Lahoz C. Gene-expression Profiling And Differential Pathways In The Sensitization And Tolerance To Allergens. J Allergy Clin Immunol 2011. [DOI: 10.1016/j.jaci.2010.12.1049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
25
|
Cortijo J, Mata M, Milara J, Donet E, Gavaldà A, Miralpeix M, Morcillo EJ. Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways. Eur Respir J 2011; 37:244-54. [PMID: 20525722 DOI: 10.1183/09031936.00182009] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Mucus hypersecretion and mucin MUC5AC overexpression are pathological features of chronic obstructive pulmonary disease (COPD). This study examines the inhibitory effect of aclidinium, a new long-acting muscarinic antagonist, on MUC5AC expression in human airway epithelial cells. MUC5AC mRNA (RT-PCR) and protein expression (ELISA and immunohistochemistry) were studied in human bronchial tissue and differentiated human airway epithelial cells activated with carbachol (100 μM) or cigarette smoke extract in the absence or presence of aclidinium. Carbachol increased MUC5AC mRNA and protein expression in human bronchus and cultured epithelial cells. Aclidinium inhibited the carbachol-induced MUC5AC mRNA and protein expression with potency (half maximal inhibitory concentration) ~1 nM in human bronchus and cultured airway epithelial cells. AG1478, a selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, inhibited carbachol-induced MUC5AC responses, indicating EGFR transactivation. Aclidinium inhibited carbachol-induced phospho-EGFR and phospho-p44/42 MAPK expression. In cultured airway epithelial cells transfected with small interfering (si)RNA against muscarinic receptor subtypes, siRNA-M3 but not siRNA-M2 blocked carbachol-induced MUC5AC expression. Cigarette smoke-induced MUC5AC upregulation in cultured airway epithelial cells was suppressed by aclidinium. In conclusion, aclidinium decreases carbachol and tobacco smoke-induced MUC5AC overexpression in human airway epithelial cells. This effect may contribute to the clinical efficacy of aclidinium in mucus hypersecretory diseases including COPD.
Collapse
Affiliation(s)
- J Cortijo
- Clinical PharmacologyFaculty of Medicine of the University of Valencia, Research Foundation of University Clinic Hospital, Valencia, Spain
| | | | | | | | | | | | | |
Collapse
|
26
|
de Paz P, Esteso MC, Alvarez M, Mata M, Chamorro CA, Anel L. Development of extender based on soybean lecithin for its application in liquid ram semen. Theriogenology 2010; 74:663-71. [PMID: 20537695 DOI: 10.1016/j.theriogenology.2010.03.022] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2009] [Revised: 03/16/2010] [Accepted: 03/25/2010] [Indexed: 11/16/2022]
Abstract
The soybean lecithin is used as a phospholipids source for the commercial extenders available for freezing bull semen which allows replacing the traditional membrane protective of animal origin (egg yolk). These extenders have been tested for freezing semen in various livestock species but specific adjustments cannot be made due to trade protection. The aim of the present study was to develop a soybean-based extender analyzing the optimal conditions of preparation, handling, and storage in order to optimize its use in liquid ram semen. Its effect on the quality of liquid ram semen was also studied. Different TES-Tris-Fructose-based extenders were prepared using two soybean types (S20 and S95) differentiated by their lipid composition (complex or simple, respectively). These extenders were made up in two temperatures: 20 degrees C (PT20) or 37 degrees C (PT37); centrifuged and filtered at 20 degrees C and stored at 15 degrees C or 5 degrees C (ST15 and ST05) for several periods (from 6 hours to 7 days). Three different concentrations of soybean (0.5%, 2%, and 3.5%) were evaluated for each extender. The amount and nature of phospholipids present in the extender were evaluated by high performance liquid chromatography (HPLC) method according to the different parameters applied in their preparation. In general, the highest quantity of phospholipids is observed in S20 extender. Centrifugation-filtration process during the extender preparation reduces by 50% the quantity of phospholipids in medium for different experiments. The quantity of phospholipids was not affected significantly by preparation temperature in S20 extender. Storage temperature affects the phospholipids present in the extender (S20 and S95) with minimum values for the storage at 5 degrees C. As for the storage time, both extenders (S20 and S95) showed a stable quantity of phospholipids in the course of the time, for 2 days at 15 degrees C and for 7 days at 5 degrees C. The extender obtained with a higher concentration of soybean (3.5%) showed a higher content of phospholipids under different conditions tested. Finally, sperm motility and viability in new extenders were analyzed. We observed that the sperm quality is not affected by storage temperature for S20 extender. Sperm motility was higher in S20-2% extender and control (UL). Our results suggest that a soybean lecithin extender obtained from S20 soybean at 20 degrees C, centrifuged and filtered, preserve the sperm motility and viability at 15 degrees C and 5 degrees C as an egg-yolk extender.
Collapse
Affiliation(s)
- P de Paz
- Cell Biology, University of León, 24071, León, Spain.
| | | | | | | | | | | |
Collapse
|
27
|
Garcia-Foncillas J, Honorato B, Caldes T, delaHoya M, Hernandez J, Landolfi S, Mata M, Gallach S, Bautista M, Benavides M. 6101 “Determina KRAS” Project: what have we learned after nine months? EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71196-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
28
|
Cortijo J, Iranzo A, Milara X, Mata M, Cerdá-Nicolás M, Ruiz-Saurí A, Tenor H, Hatzelmann A, Morcillo EJ. Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury. Br J Pharmacol 2009; 156:534-44. [PMID: 19154443 DOI: 10.1111/j.1476-5381.2008.00041.x] [Citation(s) in RCA: 65] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
BACKGROUND AND PURPOSE The effects of a phosphodiesterase 4 (PDE4) inhibitor, roflumilast, on bleomycin-induced lung injury were explored in 'preventive' and 'therapeutic' protocols and compared with glucocorticoids. EXPERIMENTAL APPROACH Roflumilast (1 and 5 mg.kg(-1).d(-1), p.o.) or dexamethasone (2.5 mg.kg(-1).d(-1), p.o.) was given to C57Bl/6J mice from day 1 to 14 (preventive) or day 7 to 21 (therapeutic) after intratracheal bleomycin (3.75 U.kg(-1)). In Wistar rats, roflumilast (1 mg.kg(-1).d(-1), p.o.) was compared with methylprednisolone (10 mg.kg(-1).d(-1), p.o.) from day 1 to 21 (preventive) or from day 10 to 21 (therapeutic), following intratracheal instillation of bleomycin (7.5 U.kg(-1)). Analyses were performed at the end of the treatment periods. KEY RESULTS Preventive. Roflumilast reduced bleomycin-induced lung hydroxyproline, lung fibrosis and right ventricular hypertrophy; muscularization of intraacinar pulmonary vessels was also attenuated. The PDE4 inhibitor diminished bleomycin-induced transcripts for tumour necrosis factor (TNFalpha), transforming growth factor (TGFbeta), connective tissue growth factor, alphaI(I)collagen, endothelin-1 and the mucin, Muc5ac, in lung, and reduced bronchoalveolar lavage fluid levels of TNFalpha, interleukin-13, TGFbeta, Muc5ac, lipid hydroperoxides and inflammatory cell counts. Therapeutic. In mice, roflumilast but not dexamethasone reduced bleomycin-induced lung alphaI(I)collagen transcripts, fibrosis and right ventricular hypertrophy. Similar results were found in the rat. CONCLUSIONS AND IMPLICATIONS Roflumilast prevented the development of bleomycin-induced lung injury, and alleviated the lung fibrotic and vascular remodeling response to bleomycin in a therapeutic protocol, the latter being resistant to glucocorticoids.
Collapse
Affiliation(s)
- J Cortijo
- Department of Pharmacology, University of Valencia, Spain
| | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Anel L, Álvarez M, Martínez-Pastor F, Gomes S, Nicolás M, Mata M, Martínez AF, Borragán S, Anel E, de Paz P. Sperm Cryopreservation in Brown Bear (Ursus arctos): Preliminary Aspects. Reprod Domest Anim 2008; 43 Suppl 4:9-17. [DOI: 10.1111/j.1439-0531.2008.01248.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
30
|
Lagunes L, Tovar B, Mata M, Vinay-Vadillo JC, De La Cruz J, Garcia HS. Effect of exogenous ethylene on ACC content and ACC oxidase activity during ripening of Manila mangoes subjected to hot water treatment. Plant Foods Hum Nutr 2007; 62:157-63. [PMID: 17906930 DOI: 10.1007/s11130-007-0057-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/07/2007] [Accepted: 09/05/2007] [Indexed: 05/17/2023]
Abstract
Mangoes (Mangifera indica L.) 'Manila' were subjected to the USDA-approved hot water treatment and then exposed to synthetic air mixtures containing 0.5, 0.75 or 1 ml l(-1) of ethylene for 6, 12 or 18 h at 25 degrees C, to induce accelerated ripening. After treatment the mangoes were allowed to ripen in air at 24-25 degrees C. The content of 1-aminocyclopropane-1-carboxylic acid (ACC) and ACC oxidase (ACO) activity increased in fruit treated with 0.5 and 0.75 ml l(-1) of ethylene for 6 or 12 h. Ethylene production was reduced in fruit treated with 1 ml l(-1) of ethylene. This was due to the decreased of ACC synthesis rather than to lower ACC oxidase activity. Treatment with 0.5 ml l(-1) of ethylene for 12 h was found best for accelerate ripening; fruits were fully ripened and edible 3 days after treatment, compared to 6-7 days for untreated mangoes.
Collapse
Affiliation(s)
- L Lagunes
- UNIDA-Instituto Tecnológico de Veracruz, M.A. de Quevedo 2779, Veracruz 91897, México
| | | | | | | | | | | |
Collapse
|
31
|
Zhou Z, Peng X, Hao S, Fink DJ, Mata M. HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia. Gene Ther 2007; 15:183-90. [PMID: 18033311 DOI: 10.1038/sj.gt.3303054] [Citation(s) in RCA: 72] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
To dissect the molecular basis of the neuroimmune response associated with the genesis of inflammatory (nociceptive) pain, we constructed a herpes simplex virus-based gene transfer vector to express the antiinflammatory cytokine interleukin-10 (IL-10), and used it to examine the effect of IL-10 expression in activated microglial cells in vitro, and in inflammatory pain in vivo. IL-10 reduced the phosphorylation of p38 mitogen-activated protein kinase (MAPK) and decreased the expression of full-length membrane spanning tumor necrosis factor-alpha (mTNFalpha) following lipopolysaccharide stimulation of microglia in vitro. IL-10 also reduced intracellular cleavage of mTNFalpha and release of the soluble cleavage product sTNFalpha. Similar effects on TNFalpha expression were observed when the cells were pretreated with a p38 MAPK inhibitor. In animals, injection of a dilute solution of formalin in the skin resulted in an increase in mTNFalpha in spinal dorsal horn, without detectable sTNFalpha. Local release of IL-10 achieved by gene transfer reduced the number of spontaneous flinches in the early and delayed phases of the formalin test of inflammatory pain. The effect of IL-10 on nocisponsive behavior correlated with a block in phosphorylation of p38 and reduced expression of 26 kDa mTNFalpha in spinal microglia. The results emphasize the key role played by membrane TNFalpha in the spinal neuroimmune response in pain caused by peripheral inflammation.
Collapse
Affiliation(s)
- Z Zhou
- Department of Neurology, University of Michigan Medical School and GRECC and Neurology Service, VA Ann Arbor Healthcare System, Ann Arbor, MI 48109-0316, USA
| | | | | | | | | |
Collapse
|
32
|
Chattopadhyay M, Mata M, Goss J, Wolfe D, Huang S, Glorioso JC, Fink DJ. Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer. Diabetologia 2007; 50:1550-8. [PMID: 17508196 DOI: 10.1007/s00125-007-0702-4] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/05/2007] [Accepted: 04/03/2007] [Indexed: 12/14/2022]
Abstract
AIMS/HYPOTHESIS The aim of this study was to determine whether prolonged expression of neurotrophin-3 (NT-3) in mice, achieved by herpes simplex virus (HSV)-mediated gene transfer with gene expression under the control of an HSV latency promoter, can provide protection against the progression of diabetic neuropathy over a 6 month period. MATERIALS AND METHODS Mice with diabetes induced by streptozotocin were inoculated s.c. into both hind feet with a non-replicating HSV vector containing the coding sequence for NT-3 under the control of the HSV latency-associated promoter 2 (LAP2) elements or with a control vector. Nerve function was evaluated by electrophysiological and behavioural measures over the course of 6 months after the onset of diabetes. RESULTS Animals inoculated with the NT-3-expressing vector, but not animals inoculated with control vector, showed preservation of sensory and motor nerve amplitude and conduction velocity measured electrophysiologically, small fibre sensory function assessed by withdrawal from heat, autonomic function measured by pilocarpine-induced sweating, skin innervation assessed by protein gene product 9.5 staining of axons, and density of calcitonin gene-related peptide terminals in the spinal cord measured by immunohistochemistry 5.5 months after vector inoculation. CONCLUSIONS/INTERPRETATION These results indicate that the continuous production of NT-3 by LAP2-driven expression of the transgene from an HSV vector over a 6 month period protects against progression of diabetic neuropathy in mice, and provide a proof-of-principle demonstration for the development of a novel therapy for preventing the progression of diabetic neuropathy.
Collapse
Affiliation(s)
- M Chattopadhyay
- Department of Neurology, University of Michigan Health System, 1500 East Medical Center Drive, Room 1914 TC, Ann Arbor, MI 48109 0316, USA
| | | | | | | | | | | | | |
Collapse
|
33
|
Chu FM, Picus J, Mata M, Kopacynski C, Foster B, Lang Z, Beckman RA, Dreicer R. Phase I study of CNTO 95, a fully human monoclonal antibody to α v integrins, docetaxel, and prednisone in hormone refractory prostate cancer patients (HRPCP). J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.15595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
15595 Background: CNTO 95 has demonstrated preclinical antitumor activity through binding to multiple av integrins, resulting in growth inhibition indirectly through anti-angiogenic effects as well as directly by inhibiting tumor cell proliferation. The target, av integrins, has been demonstrated by immunohistochemistry in a large proportion of human prostate cancer tissues. Docetaxel and prednisone have become a standard of care for HRPCP. The primary objective of this study was to evaluate the safety of combining CNTO 95 with this standard. Methods: Patients received day 1 infusions of 75 mg/m2 docetaxel together with twice daily oral prednisone in every 3 week cycles, with weekly infusions of either 5 or 10 mg/kg of CNTO 95 for 7 weeks beginning with the second docetaxel cycle, then CNTO 95 on the days of docetaxel thereafter. Patients were monitored for safety and PSA. Radiologic tumor assessments were performed at least every 4 cycles. Results: Six patients have received docetaxel and prednisone with CNTO 95 at either 5 mg/kg (n=3) or 10 mg/kg (n=3). In the 5 mg/kg group, 1 received 8 cycles then withdrew consent because of fluctuating PSA levels; 1 received 9 cycles then had soft tissue disease progression; and 1 has completed 9 cycles and remains on study treatment. In the 10 mg/kg group, all patients remain on study and have received 7, 6, and 6 cycles of treatment, respectively. There were no unexpected toxicities and only one Grade 3 toxicity (febrile neutropenia) attributed to docetaxel. A 50% decline in PSA occurred in 1 patient treated in the 10 mg/kg group. Conclusions: The combination of standard dose docetaxel and prednisone with 10 mg/kg of CNTO 95 was well tolerated and 3 new patients are planned to be treated with these doses on this study. Further study is warranted. [Table: see text]
Collapse
Affiliation(s)
- F. M. Chu
- San Bernardino Urological Associates, San Bernardino, CA; Washington University School of Medicine, St. Louis, MO; Centocor Inc, Malvern, PA; Cleveland Clinic, Cleveland, OH
| | - J. Picus
- San Bernardino Urological Associates, San Bernardino, CA; Washington University School of Medicine, St. Louis, MO; Centocor Inc, Malvern, PA; Cleveland Clinic, Cleveland, OH
| | - M. Mata
- San Bernardino Urological Associates, San Bernardino, CA; Washington University School of Medicine, St. Louis, MO; Centocor Inc, Malvern, PA; Cleveland Clinic, Cleveland, OH
| | - C. Kopacynski
- San Bernardino Urological Associates, San Bernardino, CA; Washington University School of Medicine, St. Louis, MO; Centocor Inc, Malvern, PA; Cleveland Clinic, Cleveland, OH
| | - B. Foster
- San Bernardino Urological Associates, San Bernardino, CA; Washington University School of Medicine, St. Louis, MO; Centocor Inc, Malvern, PA; Cleveland Clinic, Cleveland, OH
| | - Z. Lang
- San Bernardino Urological Associates, San Bernardino, CA; Washington University School of Medicine, St. Louis, MO; Centocor Inc, Malvern, PA; Cleveland Clinic, Cleveland, OH
| | - R. A. Beckman
- San Bernardino Urological Associates, San Bernardino, CA; Washington University School of Medicine, St. Louis, MO; Centocor Inc, Malvern, PA; Cleveland Clinic, Cleveland, OH
| | - R. Dreicer
- San Bernardino Urological Associates, San Bernardino, CA; Washington University School of Medicine, St. Louis, MO; Centocor Inc, Malvern, PA; Cleveland Clinic, Cleveland, OH
| |
Collapse
|
34
|
Abstract
We examined the role of spinal tumor necrosis factor-alpha (TNFalpha) in neuropathic pain of peripheral nerve origin. Two weeks after selective L5 spinal nerve ligation (SNL), rats exhibiting mechanical allodynia and thermal hyperalgesia showed a marked increase in full-length membrane-associated TNFalpha (mTNFalpha) in the dorsal horn of spinal cord, in the absence of detectable soluble TNFalpha peptide. Local release of the soluble p55 TNF receptor, achieved by herpes simplex virus vector-based gene transfer to dorsal root ganglion, resulted in a reduction of mTNFalpha and concomitant reductions in interleukin-1beta and phosphorylated p38 MAP kinase. Subcutaneous inoculation of soluble p55 TNF receptor expressing HSV vector into the plantar surface of the hind foot ipsilateral to the ligation 1 week before SNL delayed the development of both mechanical allodynia and thermal hyperalgesia; subcutaneous inoculation into the hind foot ipsilateral to the ligation 1 week after SNL resulted in a statistically significant reduction in mechanical allodynia and thermal hyperalgesia that was apparent 1 week after inoculation. These results suggest a novel 'reverse signaling' through glial mTNFalpha, which may be exploited to downregulate the neuroimmune reaction in spinal cord to reduce chronic neuropathic pain.
Collapse
Affiliation(s)
- S Hao
- Department of Neurology, University of Michigan, and VA Ann Arbor Healthcare Systems, Ann Arbor, MI, USA
| | | | | | | |
Collapse
|
35
|
Zaragozá R, Gimeno A, Miralles VJ, García-Trevijano ER, Carmena R, García C, Mata M, Puertes IR, Torres L, Viña JR. Retinoids induce MMP-9 expression through RARalpha during mammary gland remodeling. Am J Physiol Endocrinol Metab 2007; 292:E1140-8. [PMID: 17164434 DOI: 10.1152/ajpendo.00463.2006] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Retinoic acid (RA) is a signaling molecule in the morphogenesis of the mammary gland, modulating the expression of matrix metalloproteinases (MMPs). The aim of this paper was to study the role of RA during weaning, which consists of three events: apoptosis of the secretory cells, degradation of the extracellular matrix, and adipogenesis. CRABP II and CRBP-1 carrier proteins increased significantly during weaning compared with lactating glands but reverted to control values after the litter resuckled. The effects of RA are mediated by the nuclear receptors RARalpha, RARbeta, RARgamma, and RXRalpha, which underwent an increase in protein levels during weaning. In an attempt to elucidate the RARalpha-dependent signaling pathway, ChIP assays were performed. The results showed the binding of RARalpha to the MMP-9 promoter after 24- and 72-h weaning together with its coactivator p300; this fact could be responsible for the increase found in MMP-9 mRNA and protein levels in these conditions. Expression of related MMPs (MMP-2 and MMP-3) was also increased during weaning. Using gelatine zymography, we observed a time-dependent increase in active forms of MMP-9 and MMP-2. On the other hand, the inhibitor of MMPs, TIMP-1, was almost undetectable at 24- and 72-h weaning by Western blot. The role of retinoids in matrix remodeling is reinforced by the fact that administration of an acute dose of retinol palmitate to control lactating rats also induces MMP-9 expression. This emphasizes the importance of retinoids in vivo to regulate mammary gland involution.
Collapse
Affiliation(s)
- R Zaragozá
- Departamento de Bioquímica y Biología Molecular, Facultad de Medicina-Fundación Investigación Hospital Clínico Valencia, Universidad de Valencia, Valencia, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Stchigel AM, Umaña L, Guarro J, Mata M. Two new ascomycetes from rainforest litter in Costa Rica. Mycologia 2007; 98:815-20. [PMID: 17256584 DOI: 10.3852/mycologia.98.5.815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Two new ascomycetes, Boerlagiomyces costaricensis (Pleosporales) and Scopinella musciformis (Sordariales sensu lato), from litter samples collected in rainforests of Costa Rica, are described and illustrated. Boerlagiomyces costaricensis has globose, ostiolate ascomata covered by numerous setae-like hairs; cylindrical, fissitunicate asci without apical structures; and large, fusiform, muriform, hyaline to pale brown ascospores. Scopinella musciformis is characterized by ostiolate ascomata with a few compact clusters of hypha-like hairs distributed on the peridial surface and a long neck; ovate to ellipsoidal unitunicate asci; and small quadrangular ascospores with diagonal germ slits.
Collapse
Affiliation(s)
- A M Stchigel
- Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/ Sant Llorenç 21, 43201 Reus, Tarragona, Spain.
| | | | | | | |
Collapse
|
37
|
Garcia-Macias V, Martinez-Pastor F, Alvarez M, Paz P, Borragan S, Anel E, Mata M, Nicolas M, Anel L. 245 USE OF A TRIPLE STAIN (SYBR-14/PI/MC540) FOR VIABILITY AND CAPACITATION ASSESSMENT IN THAWED SEMEN FROM BROWN BEAR (URSUS ARCTOS). Reprod Fertil Dev 2007. [DOI: 10.1071/rdv19n1ab245] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Application of new sperm assessment techniques would improve our capability to determine the effects of cryopreservation on sperm function. This becomes relevant when germplasm banks are established for endangered species, as in the case of the brown bear in Spain. Different triple stain techniques have been used in conjunction with flow cytometry to assess various sperm attributes including viability and acrosome status. However, fluorochromes with similar emission spectra may interfere with data resolution, making acquisition and interpretation of data difficult. The double stain combination of SYBR-14 and PI (propidium iodide; max λ 617) has been widely used to differentiate live from dead spermatozoa (spz), and, more recently, merocyanine 540 (MC; max λ 555) has been used to detect a sperm membrane lipid disorder associated with sperm capacitation. In the present study, we analyzed the suitability of combining SYBR-14/PI with MC for simultaneous determination of the viability and capacitation status of frozen–thawed spermatozoa of brown bears (n = 10; semi-free ranging; Cabarceno Park, Cantabria, Spain) obtained by electroejaculation under general anesthesia (7 mg kg-1 tiletamine + zolazepan and 2 mg kg-1 ketamine). Semen was diluted (Tes-Tris-fructose, 8% glycerol, 20% egg yolk, EDTA, and Equex paste), loaded in 0.25-mL straws, and frozen in a biofreezer at 20�C min-1 to -100�C. After storage in liquid nitrogen, samples were thawed at 65�C for 6 s, divided into 2 aliquots (1–2 million spz mL-1), extended with 300 �L PBS, and stained with SYBR14 (1.2 �L) and PI (3 �L; LIVE/DEAD� Sperm Viability Kit; Molecular Probes, Inc., Eugene, OR, USA). To evaluate the possible interaction of MC on sperm viability, half of the aliquots were counterstained with 1.5 �L of MC (diluted with 2.7 �M of DMSO); the other half were not counterstained (control). All tubes were incubated at 37�C for 30 min, and assessed by flow cytometry (FACSCalibur; BD Biosciences, San Jose, CA, USA). Data were analyzed with Bland-Altman. Results indicated that MC staining was mainly confined to dead spermatozoa (22.2 � 7.7%), whereas a lower percentage of live spermatozoa (5.7 � 1.6%; P < 0.05) were also stained with MC. Possibly, the staining of dead spermatozoa with MC was due to capacitation changes induced by cryopreservation. The percentage of live spermatozoa was not different between samples counterstained with MC (68.9 � 9.2) and non-MC-stained control samples (68.6 � 8.8). Thus, we consider that MC does not influence SYBR14/PI discrimination of viable spermatozoa, and that the 3 stains can be used simultaneously. However, more studies are necessary to determine whether MC can be used to distinguish the capacitation status of brown bear thawed spermatozoa.
This work was supported by CANTUR S.A. and CICYT (CGL 2004-0278/BOS).
Collapse
|
38
|
O' Day S, Richards J, Jiao T, Mata M, Prabhakar U, Beckman R, Lang Z, Pavlick A. 218 POSTER Phase I/II study of CNTO 95, a fully human monoclonal antibody (mAb) to alpha-v integrins, in patients with metastatic melanoma. EJC Suppl 2006. [DOI: 10.1016/s1359-6349(06)70223-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
39
|
Barrio J, Cortijo J, Milara J, Mata M, Guijarro R, Blasco P, Morcillo EJ. In vitro tracheal hyperresponsiveness to muscarinic receptor stimulation by carbachol in a rat model of bleomycin-induced pulmonary fibrosis. ACTA ACUST UNITED AC 2006; 26:327-33. [PMID: 16879498 DOI: 10.1111/j.1474-8673.2006.00378.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
1 Bleomycin-induced lung injury is widely used as an experimental model to investigate the pathophysiology of pulmonary fibrosis but the alterations in the pharmacological responsiveness of airways isolated from bleomycin-exposed animals has been scarcely investigated. The aim of this study was to examine the in vitro tracheal responses to muscarinic receptor stimulation with carbachol in a rat bleomycin model. 2 Concentration-response curves to carbachol (10 nm to 0.1 mm) were obtained in tracheal rings isolated from Sprague-Dawley rats 14 days after endotracheal bleomycin or saline. The intracellular calcium signal in response to carbachol (10 microm) was measured by epifluorescence microscopy using fura-2 in primary cultures of tracheal smooth muscle cells from bleomycin- and saline-exposed rats. Circulating plasma tumour necrosis factor (TNF)-alpha/interleukin (IL)-1beta levels were measured by enzyme-linked immunosorbent assay. 3 Maximal contraction in response to carbachol was significantly greater in tracheal rings from bleomycin-exposed rats compared with controls (15.8 +/- 1.3 mN vs. 11.8 +/- 1.4 mN; n = 19, P < 0.05). 4 Carbachol (10 microm) elicited a transient increase of intracellular calcium with greater increment in tracheal smooth muscle cells from bleomycin-exposed rats compared with controls (372 +/- 42 nmvs. 176 +/- 20 nm; n = 7, P < 0.01). 5 Circulating plasma levels of TNF-alpha/IL-1beta were augmented in bleomycin-exposed rats compared with controls. Tissue incubation with TNF-alpha (100 ng ml(-1))/IL-1beta (10 ng ml(-1)) increased in vitro tracheal responsiveness to carbachol. 6 In conclusion, tracheal contraction in response to muscarinic receptor stimulation with carbachol was increased in bleomycin-exposed rats. This in vitro cholinergic hyperresponsiveness may be related to the augmented levels of inflammatory cytokines in bleomycin-exposed rats.
Collapse
Affiliation(s)
- J Barrio
- Department of Pharmacology, Faculty of Medicine, University of Valencia, Av. Blasco Ibanez 15, E-46010 Valencia, Spain
| | | | | | | | | | | | | |
Collapse
|
40
|
Guillem V, Mata M, Lluch A, Gonzalez M, Esteve J, Nomdedeu J, Calasanz M, Cervantes A, Chirivella I, Tormo M. SNPs associated with the genetic predisposition to develop therapy-related acute myelogenous leukemia after chemotherapy for breast cancer. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.8536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8536 Background: t-AML is a syndrome occurring after exposure to chemo or radiotherapy. Since for similar treatments only some patients ends developing a secondary leukemia, it has been proposed a genetic predisposition associated to this syndrome. Methods: To analyse single nucleotide polymorphisms (SNPs) on genes that could be involved on risk of developing t-AML by means of RFLP and SNP genome screening using high density microarrays .Two groups of individuals were genotyped: Group A, composed by patients that develop t-AML after chemotherapy for breast cancer (BC) and Group B (control), formed by chemotherapy treated BC patients that after a period of more than 10 years have not developed t-AML. We have studied 12 polymorphisms on genes from drug detoxification pathways (NOQ1, GSTP1), DNA repair (XPC[3 ], XRCC1[2 ], NBS1, ERCC5 and XRCC3) and DNA synthesis (MTHFR[2 ]), in which the nucleotide change implies a change in the protein sequence (nA=16, nB=18) . Alternatively, for each patient, more than 10.000 SNPs were genotyped by means of of high density microarrays (Affymetrix) (nA=12, nB=18). The alele frequencies for each SNP between two groups were compared. Results: In RFLP study, we observe two SNPs on MTHFR gene displaying remarkably different allele frequencies between BC patients (Table). In microarray study, we found 12 SNPs with differences of allele frequency higher that 45% between A and B groups, located 6 on chromosome 8. Conclusions: The results suggest that the MHFTR gene is a candidate for being studied by its possible relation with the genetic predisposition to develop t-AML after BC treatment although its functional implication with the disease must still be elucidated. Moreover, data from SNP arrays suggest that the genome regions marked by those 12 SNPs, specially those on chromosome 8, are candidate for being studied by its possible relation with the genetic predisposition to develop t-AML after BC treatment. Financed by FIS G03/008. [Table: see text] No significant financial relationships to disclose.
Collapse
Affiliation(s)
- V. Guillem
- Hospital Clinico, Valencia, Spain; Facultad de Medicina, Valencia, Spain; Hospital Clinico, Salamanca, Spain; Hospital Clinico, Barcelona, Spain; Hospital Sant Pau, Barcelona, Spain; Universidad de Navarra, Pamplona, Spain
| | - M. Mata
- Hospital Clinico, Valencia, Spain; Facultad de Medicina, Valencia, Spain; Hospital Clinico, Salamanca, Spain; Hospital Clinico, Barcelona, Spain; Hospital Sant Pau, Barcelona, Spain; Universidad de Navarra, Pamplona, Spain
| | - A. Lluch
- Hospital Clinico, Valencia, Spain; Facultad de Medicina, Valencia, Spain; Hospital Clinico, Salamanca, Spain; Hospital Clinico, Barcelona, Spain; Hospital Sant Pau, Barcelona, Spain; Universidad de Navarra, Pamplona, Spain
| | - M. Gonzalez
- Hospital Clinico, Valencia, Spain; Facultad de Medicina, Valencia, Spain; Hospital Clinico, Salamanca, Spain; Hospital Clinico, Barcelona, Spain; Hospital Sant Pau, Barcelona, Spain; Universidad de Navarra, Pamplona, Spain
| | - J. Esteve
- Hospital Clinico, Valencia, Spain; Facultad de Medicina, Valencia, Spain; Hospital Clinico, Salamanca, Spain; Hospital Clinico, Barcelona, Spain; Hospital Sant Pau, Barcelona, Spain; Universidad de Navarra, Pamplona, Spain
| | - J. Nomdedeu
- Hospital Clinico, Valencia, Spain; Facultad de Medicina, Valencia, Spain; Hospital Clinico, Salamanca, Spain; Hospital Clinico, Barcelona, Spain; Hospital Sant Pau, Barcelona, Spain; Universidad de Navarra, Pamplona, Spain
| | - M. Calasanz
- Hospital Clinico, Valencia, Spain; Facultad de Medicina, Valencia, Spain; Hospital Clinico, Salamanca, Spain; Hospital Clinico, Barcelona, Spain; Hospital Sant Pau, Barcelona, Spain; Universidad de Navarra, Pamplona, Spain
| | - A. Cervantes
- Hospital Clinico, Valencia, Spain; Facultad de Medicina, Valencia, Spain; Hospital Clinico, Salamanca, Spain; Hospital Clinico, Barcelona, Spain; Hospital Sant Pau, Barcelona, Spain; Universidad de Navarra, Pamplona, Spain
| | - I. Chirivella
- Hospital Clinico, Valencia, Spain; Facultad de Medicina, Valencia, Spain; Hospital Clinico, Salamanca, Spain; Hospital Clinico, Barcelona, Spain; Hospital Sant Pau, Barcelona, Spain; Universidad de Navarra, Pamplona, Spain
| | - M. Tormo
- Hospital Clinico, Valencia, Spain; Facultad de Medicina, Valencia, Spain; Hospital Clinico, Salamanca, Spain; Hospital Clinico, Barcelona, Spain; Hospital Sant Pau, Barcelona, Spain; Universidad de Navarra, Pamplona, Spain
| |
Collapse
|
41
|
Chattopadhyay M, Krisky D, Wolfe D, Glorioso JC, Mata M, Fink DJ. HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther 2006; 12:1377-84. [PMID: 15843809 PMCID: PMC1242112 DOI: 10.1038/sj.gt.3302533] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
We examined the utility of herpes simplex virus (HSV) vector-mediated gene transfer of vascular endothelial growth factor (VEGF) in a mouse model of diabetic neuropathy. A replication-incompetent HSV vector with VEGF under the control of the HSV ICP0 promoter (vector T0VEGF) was constructed. T0VEGF expressed and released VEGF from primary dorsal root ganglion (DRG) neurons in vitro, and following subcutaneous inoculation in the foot, expressed VEGF in DRG and nerve in vivo. At 2 weeks after induction of diabetes, subcutaneous inoculation of T0VEGF prevented the reduction in sensory nerve amplitude characteristic of diabetic neuropathy measured 4 weeks later, preserved autonomic function measured by pilocarpine-induced sweating, and prevented the loss of nerve fibers in the skin and reduction of neuropeptide calcitonin gene-related peptide and substance P in DRG neurons of the diabetic mice. HSV-mediated transfer of VEGF to DRG may prove useful in treatment of diabetic neuropathy.
Collapse
Affiliation(s)
- M Chattopadhyay
- Department of Neurology, University of Michigan Health System, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0316, USA
| | | | | | | | | | | |
Collapse
|
42
|
Zaragozá R, García-Trevijano ER, Miralles VJ, Mata M, García C, Carmena R, Barber T, Pallardó FV, Torres L, Viña JR. Role of GSH in the modulation of NOS-2 expression in the weaned mammary gland. Biochem Soc Trans 2005; 33:1397-8. [PMID: 16246128 DOI: 10.1042/bst20051397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
GSH delivery to the lactating mammary gland is essential for the maintenance of lactation as its decrease leads to apoptosis and involution of the mammary gland. In fact, it has already been demonstrated that some of the changes in gene expression found in the lactating mammary gland after forced weaning are reproduced in rats treated with buthionine sulphoximine to deplete GSH levels. An oligonucleotide microarray experiment would give us a better knowledge of the mRNA expression patterns during lactation and after weaning and the possible functions of GSH in the modulation of these events.
Collapse
Affiliation(s)
- R Zaragozá
- Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad de Valencia, Avda. Blasco Ibáñez n 15, 46010 Valencia, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Mata M, Sarriá B, Buenestado A, Cortijo J, Cerdá M, Morcillo EJ. Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells. Thorax 2005; 60:144-52. [PMID: 15681504 PMCID: PMC1747298 DOI: 10.1136/thx.2004.025692] [Citation(s) in RCA: 109] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND A common pathological feature of chronic inflammatory airway diseases such as asthma and chronic obstructive pulmonary disease (COPD) is mucus hypersecretion. MUC5AC is the predominant mucin gene expressed in healthy airways and is increased in asthmatic and COPD patients. Recent clinical trials indicate that phosphodiesterase type 4 (PDE4) inhibitors may have therapeutic value for COPD and asthma. However, their direct effects on mucin expression have been scarcely investigated. METHODS MUC5AC mRNA and protein expression were examined in cultured human airway epithelial cells (A549) and in human isolated bronchial tissue stimulated with epidermal growth factor (EGF; 25 ng/ml). MUC5AC mRNA was measured by real time RT-PCR and MUC5AC protein by ELISA (cell lysates and tissue homogenates), Western blotting (tissue homogenates) and immunohistochemistry. RESULTS EGF increased MUC5AC mRNA and protein expression in A549 cells. PDE4 inhibitors produced a concentration dependent inhibition of the EGF induced MUC5AC mRNA and protein expression with potency values (-log IC(50)): roflumilast (approximately 7.5) > rolipram (approximately 6.5) > cilomilast (approximately 5.5). Roflumilast also inhibited the EGF induced expression of phosphotyrosine proteins, EGF receptor, and phospho-p38- and p44/42-MAPK measured by Western blot analysis in A549 cells. In human isolated bronchus, EGF induced MUC5AC mRNA and protein expression was inhibited by roflumilast (1 microM) as well as the MUC5AC positive staining shown by immunohistochemistry. CONCLUSION Selective PDE4 inhibition is effective in decreasing EGF induced MUC5AC expression in human airway epithelial cells. This effect may contribute to the clinical efficacy of this new drug category in mucus hypersecretory diseases.
Collapse
Affiliation(s)
- M Mata
- Department of Pharmacology, Faculty of Medicine, University of Valencia, Spain
| | | | | | | | | | | |
Collapse
|
44
|
|
45
|
Mata M, Lohr T, Lakshminarayanan M, Lo KH, Prabhakar U. Serum Amyloid A (SAA), C-reactive protein (CRP) and IL-6 as prognostic indicators in Renal Cell Carcinoma and Prostate Cancer. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.9711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
46
|
Mata M, Oñorbe JA, Segura A. Patxi Catalá, founder of the Andalusian School of Public Health. J Epidemiol Community Health 2004; 58:360. [PMID: 15082729 PMCID: PMC1732770] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/29/2023]
Affiliation(s)
- M Mata
- Health Department, Autonomous Community of Madrid, Spain
| | | | | |
Collapse
|
47
|
Mata M, Ruíz A, Cerdá M, Martinez-Losa M, Cortijo J, Santangelo F, Serrano-Mollar A, Llombart-Bosch A, Morcillo EJ. Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats. Eur Respir J 2003; 22:900-5. [PMID: 14680076 DOI: 10.1183/09031936.03.00018003] [Citation(s) in RCA: 73] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Oxidative stress is involved in the pathogenesis of pulmonary fibrosis, therefore antioxidants may be of therapeutic value. Clinical work indicates that N-acetylcysteine (NAC) may be beneficial in this disease. The activity of this antioxidant was examined on bleomycin-induced lung damage, mucus secretory cells hyperplasia and mucin Muc5ac gene expression in rats. NAC (3 mmol x kg(-1) x day(-1)) or saline was given orally to Sprague-Dawley rats for 1 week prior to a single intratracheal instillation of bleomycin (2.5 U x kg(-1)) and for 14 days postinstillation. NAC decreased collagen deposition in bleomycin-exposed rats (hydroxyproline content was 4,257+/-323 and 3,200+/-192 microg x lung(-1) in vehicle- and NAC-treated rats, respectively) and lessened the fibrotic area assessed by morphometric analysis. The bleomycin-induced increases in lung tumour necrosis factor-alpha and myeloperoxidase activity were reduced by NAC treatment. The numbers of mucus secretory cells in airway epithelium, and the Muc5ac messenger ribonucleic acid and protein expression, were markedly augmented in rats exposed to bleomycin. These changes were significantly reduced in NAC-treated rats. These results indicate that bleomycin increases the number of airway secretory cells and their mucin production, and that oral N-acetylcysteine improved pulmonary lesions and reduced the mucus hypersecretion in the bleomycin rat model.
Collapse
Affiliation(s)
- M Mata
- Dept of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain
| | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Cremata JA, Sorell L, Montesino R, Garcia R, Mata M, Cabrera G, Galvan JA, Garcia G, Valdes R, Garrote JA. Hypogalactosylation of serum IgG in patients with coeliac disease. Clin Exp Immunol 2003; 133:422-9. [PMID: 12930370 PMCID: PMC1808795 DOI: 10.1046/j.1365-2249.2003.02220.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Coeliac disease (CD) is described as an autoimmune enteropathy associated with the presence of IgG and IgA antigliadin and antitransglutaminase autoantibodies. While of diagnostic significance, the role of these autoantibodies in the immunopathogenesis of CD is elucidated. An inappropriate T cell immune response to gluten is also involved in the pathogenesis of CD, as evidenced by autoantibody switching. The N-glycans released from serum IgG of CD patients and three groups of healthy controls, of differing age ranges, were analysed by NH2-high performance liquid chromatography (HPLC). The fucosylated biantennary N- glycans were the most abundant neutral oligosaccharides; in particular, the agalacto form (G0F) showed a mean value of 42% (s.d. +/- 7.4), 30% (s.d. +/- 5.9), 26% (s.d. +/- 4.2) and 35% (s.d. +/- 6.8) for CD patients, healthy children, healthy adults under 40 and healthy adults over 40 years old, respectively. The ratio of asialo agalacto fucosylated biantenna to asialo monogalacto fucosylated biantenna (G0F)/(G1F) for CD patients showed a significant increase compared to healthy children (P < 0.0002), healthy adults under 40 (P < 0.0002) and healthy adults over 40 years old (P < 0.01). Hypogalactosylation was more pronounced for CD patients than for the patients with other autoimmune diseases such as rheumatoid arthritis or psoriatic arthritis.
Collapse
Affiliation(s)
- J A Cremata
- Physical-Chemistry Division; Center for Genetic Engineering and Biotechnology, Havana, Cuba.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Abstract
Self Injurious Behaviour (SIB) is a deliberate harm to the body that may lead to factitial injuries. Its origin may be functional or biological and it has a higher prevalence in females and in psychologically impaired individuals. Seventy per cent of autistic patients have SIB. Seventy-five per cent of factitial injuries are located in the head and neck region. A paediatric case report concerning a 4-year-old autistic female is presented. Detailed medical history, physical examination, clinical intraoral and radiographic examination, incisional biopsy, neuropaediatrical, psychological and speech evaluation were undertaken. Diagnosis included hypochromic macrocytic anaemia, caries, coronal fracture, factitial ulcer, factitial periodontitis, self-extraction of primary teeth and permanent teeth buds, non-specific oral ulcer with inflammatory reaction, mild mental retardation, speech impairment, autistic syndrome and self injurious behaviour consisting of putting fingers and foreign objects in the gingiva, fingernail biting and hair pulling. Differential diagnosis included hystiocitosis X, prepuberal periodontitis and leukocyte adhesion deficiency. Dental preventive and restorative treatment was performed. Non-contingent reinforcement therapy was successfully used to diminish SIB. Treatment of factitial oral injuries must be interdisciplinary and requires cooperation of the patient, the parents, health care providers, and medical team.
Collapse
Affiliation(s)
- A C Medina
- Universidad Central de Venezuela Dental School, Caracas, Venezuela.
| | | | | | | |
Collapse
|
50
|
Blesa S, Cortijo J, Mata M, Serrano A, Closa D, Santangelo F, Estrela JM, Suchankova J, Morcillo EJ. Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen. Eur Respir J 2003; 21:394-400. [PMID: 12661991 DOI: 10.1183/09031936.03.00039602] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Oxidative stress is involved in the pathophysiology of inflammatory airway diseases including asthma; therefore, antioxidants might be of clinical benefit in asthma treatment. In the present study, the effects of N-acetylcysteine on sensitised brown Norway rats were examined. N-Acetylcysteine (3 mmol kg body weight(-1) administered orally) was given daily for 1 week before challenge and various antigen-induced pulmonary responses were studied. Antigen exposure increased lipid peroxidation in bronchoalveolar lavage fluid (BALF) and oxidised glutathione levels in lung tissue 2 h after challenge. Lung nuclear transcription factor-KB-binding activity was increased 2 h after challenge, and BALF tumour necrosis factor-alpha and inducible nitric oxide synthase expression in lungs peaked 4 h after challenge. Expression of intercellular adhesion molecule-1 and mucin MUC5AC was also increased 4 h after challenge. These changes in oxidant status, transcription factor activation, and inflammatory cytokine and gene expression were reduced by N-acetylcysteine. This thiol did not affect the immediate bronchospasm reaction to antigen in anaesthetised rats but inhibited airways hyperresponsiveness to 5-hydroxytryptamine and the augmented eosinophil numbers in BALF, which appear 24 h after exposure of conscious rats to antigen aerosol, and abolished antigen-induced extravasation of Evans blue into BALF. These results indicate that oral N-acetylcysteine exerts an antioxidant protective effect and attenuates pulmonary inflammation in experimental asthma.
Collapse
Affiliation(s)
- S Blesa
- Dept of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain
| | | | | | | | | | | | | | | | | |
Collapse
|